/*
Navicat MySQL Data Transfer

Source Server         : 本地服务器
Source Server Version : 50717
Source Host           : localhost:3306
Source Database       : spider

Target Server Type    : MYSQL
Target Server Version : 50717
File Encoding         : 65001

Date: 2019-01-21 13:59:31
*/

SET FOREIGN_KEY_CHECKS=0;

-- ----------------------------
-- Table structure for cellbank_production
-- ----------------------------
DROP TABLE IF EXISTS `cellbank_production`;
CREATE TABLE `cellbank_production` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `KCLBNo` varchar(100) DEFAULT NULL,
  `ProductName` varchar(100) DEFAULT NULL,
  `Distributibility` varchar(100) DEFAULT NULL,
  `CellLineSTRProfile` varchar(255) DEFAULT NULL,
  `Origin` varchar(200) DEFAULT NULL,
  `Species` varchar(100) DEFAULT NULL,
  `Strain` varchar(200) DEFAULT NULL,
  `VirusSusceptibilit` varchar(500) DEFAULT NULL,
  `VirusResistance` varchar(500) DEFAULT NULL,
  `Reversetranscritase` varchar(500) DEFAULT NULL,
  `Tumorigenecity` varchar(200) DEFAULT NULL,
  `Isoenzyme` varchar(255) DEFAULT NULL,
  `Karyology` varchar(400) DEFAULT NULL,
  `CellularMorphology` varchar(100) DEFAULT NULL,
  `Production` varchar(500) DEFAULT NULL,
  `Histocompatibility` varchar(255) DEFAULT NULL,
  `GrowthPattern` varchar(100) DEFAULT NULL,
  `Histopathology` varchar(200) DEFAULT NULL,
  `Differentiation` varchar(255) DEFAULT NULL,
  `FreezingMedia` varchar(150) DEFAULT NULL,
  `OriginalMedia` varchar(300) DEFAULT NULL,
  `KCLBMedia` varchar(500) DEFAULT NULL,
  `Depositor` varchar(500) DEFAULT NULL,
  `Subculture` varchar(500) DEFAULT NULL,
  `Reference` varchar(500) DEFAULT NULL,
  `Note` varchar(1500) DEFAULT NULL,
  `Hit` varchar(100) DEFAULT NULL,
  `SplitRatio` varchar(100) DEFAULT NULL,
  `MediaChange` varchar(300) DEFAULT NULL,
  PRIMARY KEY (`id`)
) ENGINE=InnoDB AUTO_INCREMENT=844 DEFAULT CHARSET=utf8;

-- ----------------------------
-- Records of cellbank_production
-- ----------------------------
INSERT INTO `cellbank_production` VALUES ('586', '21611', 'ACHN', 'Yes', '', 'kidney', 'human - male, 22 years old,  Caucasian', '', '', '', '', 'yes, in nude mice', '', '', 'epithelial', '', '', 'monolayer', 'adenocarcinoma, renal', 'adenocarcinoma, renal', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'MEM (Eagle) in Earle\'s BSS with non-essential amino acids, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Dulbecco\'s modified Eagle\'s medium, 90%; heat inactivated fetal bovine serum (FBS) 10%', '', '', '', 'growth is inhibited by human interferon', '1967', '', '');
INSERT INTO `cellbank_production` VALUES ('587', '21598', 'A-673', 'Yes', '', 'muscle', 'human - female, 15 years old', '', '', '', '', 'yes, in immunosuppressed mice', '', '', 'fibroblast', '', '', '', 'rhabdomyosarcoma', 'rhabdomyosarcoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Dulbecco', 'Dulbecco', '', '', '', '', '2109', '', '');
INSERT INTO `cellbank_production` VALUES ('588', '30037.1', 'Caco-2', 'Yes', '', 'colon', 'human - male, 72 years old, caucasian', '', '', '', '', '', '', '', 'epithelial', '', '', 'monolayer', 'adenocarcinoma', 'adenocarcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Minimum essential medium (Eagle) in Earle', 'Minimum essential medium, 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', 'Remove medium, add fresh 0.25 % trypsin 0.02 % EDTA solution, stand culture flask at 37', '', '', '5735', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('589', '80006', 'B16 BL6', 'Yes', '', '', 'mouse', '', '', '', '', '', '', '', '', '', '', 'monolayer', 'melanoma', 'melanoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Eagle\'s Minimum Essential Medium, 90%; heat inactivated fetal bovine serum (FBS), 10% or Dulbecco\'s modified Eagle\'s Medium, 90%, heat inactivated fetal bovine serum (FBS), 10%', 'Eagle\'s Minimum Essential Medium, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Isaiah J, Fidler', '', '', '', '3661', '', '');
INSERT INTO `cellbank_production` VALUES ('590', '21611', 'ACHN', 'Yes', '', 'kidney', 'human - male, 22 years old,  Caucasian', '', '', '', '', 'yes, in nude mice', '', '', 'epithelial', '', '', 'monolayer', 'adenocarcinoma, renal', 'adenocarcinoma, renal', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'MEM (Eagle) in Earle\'s BSS with non-essential amino acids, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Dulbecco\'s modified Eagle\'s medium, 90%; heat inactivated fetal bovine serum (FBS) 10%', '', '', '', 'growth is inhibited by human interferon', '1967', '', '');
INSERT INTO `cellbank_production` VALUES ('591', '30054', 'Calu-1', 'Yes', '', 'lung; pleural effusion', 'human', '', '', '', '', '', '', '', '', '', '', 'adherent', 'epidermoid carcinoma; epithelial', 'epidermoid carcinoma; epithelial', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'McCoys 5a Medium Modified, 90%; fetal bovine serum (FBS), 10%', 'McCoys 5a Medium Modified, 90%; fetal bovine serum (FBS), 10%', '', '', '', 'Penicillin-streptomycin were added to culture media (final concentration, 100 U/mL)', '179', '', '');
INSERT INTO `cellbank_production` VALUES ('592', '60051', 'AT-3.1', 'Yes', '', 'prostate', 'rat - Copenhagen', '', '', '', '', '', '', '', '', '', '', 'Suspension', 'carcinoma', 'carcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Prof. Untae Kim', '', 'For the more information for this cell line, please see the reference (metastasis-cell lines, Untaekim.pdf) uploaded in the KCLB web.', 'higly metastatic prostate carcinoma cell line', '1489', '', '');
INSERT INTO `cellbank_production` VALUES ('593', '30047', 'Caki-2', 'Yes', '', 'kidney', 'human - male, 69 years old, Caucasian', '', '', '', '', '', 'Me-2,2;PGM3,1-2;PGM1,1;ES-D,1-2;AK-1,1;GLO-1,1-2;G6PD,B', '(P8) hypopentaploid to hypohexaploid (+A2, +A3,+B,+C,+D,+F,+G,-A) with abnormalities', 'epithelial', '', '', 'monolayer', 'carcinoma, clear cell', 'carcinoma, clear cell', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'McCoy', 'Dulbecco', '', 'Remove medium, rinse with fresh 0.25% trypsin solution, remove trypsin and let the culture sit at room temperature (or at 37C) until the cells detach (about 10 min). Add fresh medium, aspirate and dispense into new flasks. Subculture every 6 to 8 days.', 'Fogh J et al. Absence of Hela cell contamination in 169 cell lines derived from human tumors. J.Natl.Cancer Inst. 58: 209-214, 1977Goodfellow M et al. One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J.Natl.Cacer Inst. 59: 221-226, 1977', '', '1062', '1:3 to 1:6', '2 to 3 times weekly');
INSERT INTO `cellbank_production` VALUES ('594', '30054.1G', 'Calu-1', 'Yes', '', 'lung; pleural effusion', 'human', '', '', '', '', '', '', '', '', '', '', 'adherent', 'epidermoid carcinoma; epithelial', 'epidermoid carcinoma; epithelial', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'McCoys 5a Medium Modified, 90%; fetal bovine serum (FBS), 10%', 'McCoys 5a Medium Modified, 90%; fetal bovine serum (FBS), 10%', '', '', '', '', '159', '', '');
INSERT INTO `cellbank_production` VALUES ('595', '30075', 'Caov-3', 'Yes', '', 'ovary; epithelial', 'human', '', '', '', '', '', '', '', '', '', '', 'adherent', 'adenocarcinoma', 'adenocarcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Dulbeccos Modified Eagles Medium, 90%; fetal bovine serum (FBS), 10%', 'Dulbeccos Modified Eagles Medium, 90%; fetal bovine serum (FBS), 10%', '', '', '', 'Penicillin-streptomycin were added to culture media (final concentration, 100 U/mL)', '352', '', '');
INSERT INTO `cellbank_production` VALUES ('596', '21682', 'AsPC-1', 'Yes', '', 'pancreas; ascites', 'human - female, 62 years old, Caucasian', '', '', '', '', '', '', '', '', 'carcinoembryonic antigen(CEA); human pancreas associated antigen; human pancreas specific antigen; mucin', '', 'monolayer', 'adenocarcinoma', 'adenocarcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with sodium pyruvate, 80%; heat inactivated fetal bovine serum (FBS), 20%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', 'Remove medium, rinse monolayer with  fresh 0.25 % trypsin, 0.02 % versene solution, remove trypsin and let the culture sit at 37', 'Chen WH et al . Human pancreatic adenocarcinoma: in vitro and in vivo morphology of a new tumor line established from ascites. In vitro 18:24-34, 1982', 'The line was derived from nude mouse xenografts initiated with cells from the ascites of a patient with cancer of the pancreas.', '2369', '', '');
INSERT INTO `cellbank_production` VALUES ('597', '21620', 'A172', 'Yes', '', 'brain', 'human - human', '', '', '', '', '', '', '', '', '', '', '', 'glioblastoma', 'glioblastoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Dulbecco', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', 'J Nat', '', '3732', '', '');
INSERT INTO `cellbank_production` VALUES ('598', '30075', 'Caov-3', 'Yes', '', 'ovary; epithelial', 'human', '', '', '', '', '', '', '', '', '', '', 'adherent', 'adenocarcinoma', 'adenocarcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Dulbeccos Modified Eagles Medium, 90%; fetal bovine serum (FBS), 10%', 'Dulbeccos Modified Eagles Medium, 90%; fetal bovine serum (FBS), 10%', '', '', '', 'Penicillin-streptomycin were added to culture media (final concentration, 100 U/mL)', '352', '', '');
INSERT INTO `cellbank_production` VALUES ('599', '80006', 'B16 BL6', 'Yes', '', '', 'mouse', '', '', '', '', '', '', '', '', '', '', 'monolayer', 'melanoma', 'melanoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Eagle\'s Minimum Essential Medium, 90%; heat inactivated fetal bovine serum (FBS), 10% or Dulbecco\'s modified Eagle\'s Medium, 90%, heat inactivated fetal bovine serum (FBS), 10%', 'Eagle\'s Minimum Essential Medium, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Isaiah J, Fidler', '', '', '', '3661', '', '');
INSERT INTO `cellbank_production` VALUES ('600', '10107', 'C6', 'Yes', '', 'glial cell', 'rat', '', 'vesicular stomatitis (Indiana); vaccinia; herpes simplex', 'poliovirus 3', 'negative', '', '', '', 'fibroblast', 'S-100 protein; produce glyceralphosphate dehydrogenase in response to glucocorticoids; somatotropin', '', 'monolayer', 'glioma', 'glioma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Ham\'s F10 medium, 82.5%; horse serum, 15%; FBS, 2.5%', 'Dulbecco\'s modified Eagle\'s medium, 90%; heat inactivated fetal bovine serum (FBS) 10%', '', '', 'Science, 161:370, 1968', 'S-100 production increases ten fold as cells grow from low density to confluency', '3078', '', '');
INSERT INTO `cellbank_production` VALUES ('601', '21459', 'CCD-18Co', 'Yes', '', 'colon', 'human - female, 2.5 months old, Black', '', '', '', '', '', '', '', 'fibroblast', '', '', 'monolayer', 'normal', 'normal', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'MEM (Eagle) in Earle', 'DMEM with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', 'Science 230:943-945', 'the line is at population doubling level(PDL)=22, and begins to senesce at about PDL=42; growth of the cells is enhanced by addition of tumor necrosis factor alpha (TNF alpha) to the medium', '2176', '', '');
INSERT INTO `cellbank_production` VALUES ('602', '21739', 'AGS', 'Yes', '', 'stomach', 'human - female, 54 years old, Caucasian', '', '', '', '', 'yes, in athymic BALB/c mice', '', '', 'epithelial', '', '', 'monolayer', 'adenocarcinoma', 'adenocarcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Ham', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', 'Cancer Res, 43:1703-1709, 1983; Invest New Drugs, 1:117-127, 1983', 'the AGS cell line was derived from fragments of a tumor resected from a patient who had received no prior therapy; the cells have a plating efficiency of 34% in the medium below; the line was cured at the ATCC of a prior mycoplasma infection', '6572', '', '');
INSERT INTO `cellbank_production` VALUES ('603', '30053', 'A-427', 'Yes', '', 'lung', 'human - male, 52 years old, Caucasian', '', '', '', '', 'Yes, in nude mice; forms an undifferentiated tumor suggestive o adenocarcinoma', 'PGM3,1;PGM1,1-2;ES-D,1;AK-1,2;GLO-1,1;G6PD,B', '(P60) hypotriploid to hypertriploid with abnormalities', 'epithelial', '', '', 'monolayer', 'carcinoma', 'carcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Minimum essential medium (Eagle) in Earle', 'Dulbecco', '', 'Remove medium, rinse with fresh 0.25% trypsin solution, remove trypsin and let the culture sit at room temperature (or 37C) until the cells detach (about 10min).Add fresh medium, aspirate and dispense into new flasks.Subculture every 6 to 8 days.', 'Fogh J et al. Absence of HeLa cell contamination in 169 cell lines derived from human tumors. J.Natl.Cancer Inst. 58: 209-214, 1977. Goodfellow M et al. One humdred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J.Natl.Cancer Inst. 59: 221-226, 1977', '', '3617', '1:2 to 1:6', 'twice per week');
INSERT INTO `cellbank_production` VALUES ('604', '30056', 'Calu-6', 'Yes', '', 'unknown; probably lung', 'human - female, 61 years old, Caucasian', '', '', '', '', 'Yes, in nude mice; forms poorly differentiated carcinoma', 'Me-2,1;PGM3,1;PGM1,2;ES-D,1;AK-1,1;GLO-1,2;G6PD,B', 'The stemline chromosome number is hypotriploid and the 2S component occurred at 5.8%.', 'epithelial', '', '', 'monolayer', 'carcinoma, anaplastic', 'carcinoma, anaplastic', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Minimum essential medium (Eagle) in Earle', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', 'Remove medium, rinse with fresh 0.25% trypsin, 0.02% EDTA solution, remove trypsin and let the culture sit at room temperature (or 37C) until the cells detach (about 10min).Add fresh medium, aspirate and dispense into new flasks.Subculture every 6 to 8 days.', 'J.Fogh and G.Trempe, In: Human Tumor Cells In Vitro, PP.115-159, J. Fogh(ed), Plenum Press, New York, 1975. Fogh J et al. Absence of HeLa cell contamination in 169 cell lines derived from human tumors. J.Natl.Cancer Inst. 58: 209-214, 1977. Goodfellow M et al. One humdred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J.Natl.Cancer Inst. 59: 221-226, 1977', '', '1215', '1:2 to 1:8', '2 to 3 times per week');
INSERT INTO `cellbank_production` VALUES ('605', '10053.1', 'Clone M-3; Cloudman S91 melano', 'Yes', '', 'melanocyte', 'mouse - male', '(C X DBA)F1', '', '', '', 'yes, in C57BL mice', '', '', 'epithelial', 'melanin', '', 'monolayer', 'melanoma; melanotic', 'melanoma; melanotic', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Ham\'s F10 medium, 82.5%; horse serum, 15%; FBS, 2.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', 'Science, 154:1186, 1966', 'tested and found negative for ectromelia virus (mousepox)', '2771', '', '');
INSERT INTO `cellbank_production` VALUES ('606', '10008', 'CCRF S-180 II', 'Yes', '', '', 'mouse - adult, Mus musculus', 'CFW', '', 'poliovirus 1', 'positive', 'yes, in CFW mice', '', '', 'fibroblast', '', '', 'monolayer', 'sarcoma', 'sarcoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Eagle\'s Minimum Essential Medium in Earle\'s BSS with non-essential amino acids, 95%; bovine calf serum (BCS), 5%', 'Dulbecco\'s modified Eagle\'s medium, 90%; heat inactivated fetal bovine serum (FBS) 10%', '', '', 'Cancer Res. 20:930, 1960', 'tested and found negative for ectromelia virus (mousepox)', '1480', '', '');
INSERT INTO `cellbank_production` VALUES ('607', '80003', 'A375P', 'Yes', '', '', 'human', '', '', '', '', '', '', '', '', '', '', 'monolayer', 'melanoma, low metastatic', 'melanoma, low metastatic', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Eagle\'s Minimum Essential Medium, 90%; heat inactivated fetal bovine serum (FBS), 10% or Dulbecco\'s modified Eagle\'s Medium, 90%, heat inactivated fetal bovine serum (FBS), 10%', 'Dulbecco\'s modified Eagle\'s Medium, 90%, heat inactivated fetal bovine serum (FBS), 10%', 'Isaiah J, Fidler', '', '', '', '3026', '', '');
INSERT INTO `cellbank_production` VALUES ('608', '10120.1', 'CCRF-HSB-2; CCRF HSB-2; HSB-2', 'Yes', '', 'T cell; T lymphoblast', 'human - male, 11.5 years old,  Caucasian', '', '', '', '', 'yes, in syrian hamsters', 'G6PD, B', '', 'lymphoblast', '', '', 'suspension', 'leukemia, acute lymphoblastic', 'leukemia, acute lymphoblastic', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Iscove', 'Dulbecco���s Modified Eagle Medium, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', 'M.D. Anderson Hospital and Tumor Institue Monograph 21, 1967', 'derived from the same buffy coat preparation as KCLB 120 (CCRF-SB) by serially transplanting into newborn syrian hamsters.', '1368', '', '');
INSERT INTO `cellbank_production` VALUES ('609', '30056', 'Calu-6', 'Yes', '', 'unknown; probably lung', 'human - female, 61 years old, Caucasian', '', '', '', '', 'Yes, in nude mice; forms poorly differentiated carcinoma', 'Me-2,1;PGM3,1;PGM1,2;ES-D,1;AK-1,1;GLO-1,2;G6PD,B', 'The stemline chromosome number is hypotriploid and the 2S component occurred at 5.8%.', 'epithelial', '', '', 'monolayer', 'carcinoma, anaplastic', 'carcinoma, anaplastic', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Minimum essential medium (Eagle) in Earle', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', 'Remove medium, rinse with fresh 0.25% trypsin, 0.02% EDTA solution, remove trypsin and let the culture sit at room temperature (or 37C) until the cells detach (about 10min).Add fresh medium, aspirate and dispense into new flasks.Subculture every 6 to 8 days.', 'J.Fogh and G.Trempe, In: Human Tumor Cells In Vitro, PP.115-159, J. Fogh(ed), Plenum Press, New York, 1975. Fogh J et al. Absence of HeLa cell contamination in 169 cell lines derived from human tumors. J.Natl.Cancer Inst. 58: 209-214, 1977. Goodfellow M et al. One humdred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J.Natl.Cancer Inst. 59: 221-226, 1977', '', '1215', '1:2 to 1:8', '2 to 3 times per week');
INSERT INTO `cellbank_production` VALUES ('610', '21555', 'A-431', 'Yes', '', '', 'human - female, 85 years old', '', '', '', '', 'yes, in immunosuppressed mice', 'G6PD, B; PGM1, 1; PGM3, 1; ES-D, 1; Me-2, 0; AK-1, 1; GLO-1, 2', '', 'epithelial', '', '', 'monolayer', 'carcinoma, epidermoid', 'carcinoma, epidermoid', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Dulbecco', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', 'J Nat', '', '4194', '', '');
INSERT INTO `cellbank_production` VALUES ('611', '10222', 'COLO 205', 'Yes', '', 'colon', 'human - male, 70 years old,  Caucasian', '', '', '', 'negative', 'yes, in nude mice', 'G6PD,B;PGM1,1-2;PGM3,1-2;6PDG,A;ES-D,1-2;PEP-D,1', '', 'epithelial', 'carcinoembryonic antigen(CEA) o.5ng/10exp6 cells/10days; keratin', '', 'cells grow loosely a', 'adenocarcinoma', 'adenocarcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', 'Cancer Res. 38:1345-1355, 1978', 'CSAp negative(CSAp-); the lines was derived from tissue from the same patient as COLO 201(KLCB 10221); the cells are positive for keratin by immunoperoxidase staining', '1542', '', '');
INSERT INTO `cellbank_production` VALUES ('612', '30053', 'A-427', 'Yes', '', 'lung', 'human - male, 52 years old, Caucasian', '', '', '', '', 'Yes, in nude mice; forms an undifferentiated tumor suggestive o adenocarcinoma', 'PGM3,1;PGM1,1-2;ES-D,1;AK-1,2;GLO-1,1;G6PD,B', '(P60) hypotriploid to hypertriploid with abnormalities', 'epithelial', '', '', 'monolayer', 'carcinoma', 'carcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Minimum essential medium (Eagle) in Earle', 'Dulbecco', '', 'Remove medium, rinse with fresh 0.25% trypsin solution, remove trypsin and let the culture sit at room temperature (or 37C) until the cells detach (about 10min).Add fresh medium, aspirate and dispense into new flasks.Subculture every 6 to 8 days.', 'Fogh J et al. Absence of HeLa cell contamination in 169 cell lines derived from human tumors. J.Natl.Cancer Inst. 58: 209-214, 1977. Goodfellow M et al. One humdred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J.Natl.Cancer Inst. 59: 221-226, 1977', '', '3617', '1:2 to 1:6', 'twice per week');
INSERT INTO `cellbank_production` VALUES ('613', '30075.1G', 'Caov-3', 'Yes', '', 'ovary; epithelial', 'human', '', '', '', '', '', '', '', '', '', '', 'adherent', 'adenocarcinoma', 'adenocarcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Dulbeccos Modified Eagles Medium, 90%; fetal bovine serum (FBS), 10%', 'Dulbeccos Modified Eagles Medium, 90%; fetal bovine serum (FBS), 10%', '', '', '', '', '182', '', '');
INSERT INTO `cellbank_production` VALUES ('614', '10220.1', 'COLO 320 HSR', 'Yes', '', 'colon', 'human - female, 55 years old, Caucasian', '', '', '', 'negative', 'yes, in nude mice', 'PGM1, 1; PGM3, 2; G6PD, B; PEP-D, 1; 6PGD, A;ES-D, 1', 'marker chromosomes with homogeneously staining regions were observed and the double minute chromosomes appeared in much lower frequency than the parental line COLO 320DM', 'rounded and refracti', 'serotonin; norepinephrine; epinephrine; adrenocorticotropic hormone(ACTH); parathyroid hormone', '', 'The cells grows loos', 'adenocarcinoma; Dukes', 'adenocarcinoma; Dukes', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', 'Shake flask, pour one-half of the medium into a new flask and add fresh medium to both flasks. Cells remaining attached may be removed (if desired) using a standard trypsin protocol. Subculture once per week.', 'Clevenstine EC et al. Cell lines fromhuman colon carcinoma with unusual cell products, double minutes, and homogeneously staining regions. Cancer Res. 39: 4914-4924. 1979. Trainer DL et al. Biological characterization and oncogene expression in human colorectal carcinoma cell lines. Int. J. Cancer 41: 287-296, 1988', 'CEA(-), CSAp(-), colon antigen 3(+); This line is a subline of COLO 320DM (KCLB 10220). The cells are weakly positive for keratins and vimentin', '1090', '', '');
INSERT INTO `cellbank_production` VALUES ('615', '21598', 'A-673', 'Yes', '', 'muscle', 'human - female, 15 years old', '', '', '', '', 'yes, in immunosuppressed mice', '', '', 'fibroblast', '', '', '', 'rhabdomyosarcoma', 'rhabdomyosarcoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Dulbecco', 'Dulbecco', '', '', '', '', '2109', '', '');
INSERT INTO `cellbank_production` VALUES ('616', '21947', 'CCD-986sk', 'Yes', '', 'skin; fibroblast', 'human - human', '', '', '', '', '', '', '', 'fibroblast', '', '', 'monolayer', 'normal', 'normal', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'IMDM ; FBS,10%', 'IMDM ; FBS,10%', '', '', '', '', '10785', '', '');
INSERT INTO `cellbank_production` VALUES ('617', '40195', 'CEM-CM3', 'Yes', '', 'T cell; T lymphoblast', 'human - female, 4 years old, Caucasian', '', '', '', '', '', '', '', 'lymphoblast', 'this line was derived from CCRF-CEM by selecting for resistance to 8-azaguanine; the line has been used as a fusion partner in the production of human-human T cell hybridomas', '', 'suspension', 'leukemia, acute lymphoblastic', 'leukemia, acute lymphoblastic', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with 15 mcg/ml 8-azaguanine, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Dulbecco\'s modified Eagle\'s medium, 90%; heat inactivated fetal bovine serum (FBS) 10%', '', '', 'Clin Res, 31:734A, 1983; Cathcart, M.K. and M. Murakami, Nonspecific suppression of antibody synthesis by products of human T lymphocyte hybridomas. Use of a newly selected parent fusion line. In: T cell Hybrodomas (M.J. Taussig, ed.) CRC press, Boca Raton, FL. 1985 p. 227-236; Cathcart, M.K. Human T Lymphocyte hybridomas: Production of nonspecific suppressor factors of antibody synthesis. 5th International Congress of Immunology, Kyoto, Japna, August, 1983, Abstract', 'this line was derived from CCRF-CEM by selecting for resistance to 8-azaguanine; the line has been used as a fusion partner in the production of human-human T cell hybridomas', '1179', '', '');
INSERT INTO `cellbank_production` VALUES ('618', '10119', 'CCRF-CEM; CCRF CEM', 'Yes', '', 'T cell; T lymphoblast', 'human - female, 4 years old, Caucasian', '', '', '', 'negative', 'yes, in syrian hamsters', 'G6PD, B', '', 'lymphoblast', '', 'CD3 B(37%), CD4(50%), CD5(95%), CD7(77%)', 'suspension', 'leukemia, acute lymphoblastic', 'leukemia, acute lymphoblastic', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640, 80%; heat inactivated fetal bovine serum (FBS), 20%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', 'Cancer, 18:522-529, 1965', '', '1957', '', '');
INSERT INTO `cellbank_production` VALUES ('619', '10061', 'CHO-K1', 'Yes', '', 'ovary', 'hamster - female; Chinese hamster', 'Cricetulus griseus', 'vesicular stomatitis(Indiana); Getah virus', 'poliovirus 2; modoc virus; Button Willow virus', 'negative', '', '', '20', 'epithelial', '', '', 'monolayer', 'normal', 'normal', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Ham\'s F12 medium, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', 'J Exp Med, 108:945, 1958', 'The cells require proline for growth', '4599', '', '');
INSERT INTO `cellbank_production` VALUES ('620', '10226', 'C3H/10T1/2,Clone 8', 'Yes', '', 'embryo', 'mouse - embryo, Mus musculus', 'C3H', '', '', 'negative', 'no', '', '', 'fibroblast', '', 'H-2k', 'monolayer', '', '', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Basal medium(Eagle) in Earle\'s BSS, 90%; heat-inactivated FBS, 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', 'Cancer Res. 33:3231-3238, 1973', 'contact sensitive; no detectable background spontaneous transformation; highly susceptible to transformation by chemical agents; tested and found negative for ectromelia virus (mousepox)', '1711', '', '');
INSERT INTO `cellbank_production` VALUES ('621', '30045', 'A-704', 'Yes', '', 'kidney', 'human - male, 78 years old', '', '', '', '', 'No', 'Me-2,1;PGM3.1-2;PGM1,1;ES-D,1;AK-1,1;GLO-1,2;G6PD,B', '(P59) diploid to hyperdiploid, hypertriploid to hypertetraploid with abnormalities including breaks, dendritics and endoreduplication', 'epithelial', '', '', 'monolayer', 'adenocarcinoma', 'adenocarcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Minimum essential medium Eagle in Earle', 'Dulbecco', '', 'Remove medium, rinse with fresh 0.25% trypsin solution, remove trypsin and let the culture sit at room temperature (or at 37C) until the cells detach (about 10 min). Add fresh medium, aspirate and dispense into new flasks. Subculture every 6 to 8 days.', 'Giard DJ at al. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J.Natl.Cancer Inst. 51: 1417-1423, 1973', '', '1707', '1:3 to 1:4', '2 to 3 times weekly');
INSERT INTO `cellbank_production` VALUES ('622', '21550', 'CaSki', 'Yes', '', 'cervix, uterine', 'human - female, 40 years old, Caucasian', '', '', '', '', '', 'G6PD, B', '', 'epithelial', 'beta subunit of human chorionic gonadotropin (hCG); tumor associated antigen', '', 'monolayer', 'carcinoma, epidermoid; metastasis', 'carcinoma, epidermoid; metastasis', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', 'Science, 196:1456-1458, 1977; J Virol, 61:962-971, 1987', 'the line was established from cells from a metastasis in the small bowel mesentery; the cells are reported to contain an integrated human papillomavirus type 16 genome (HPV-16, about 600 copies per cell)', '1355', '', '');
INSERT INTO `cellbank_production` VALUES ('623', '30046', 'Caki-1', 'Yes', '', 'kidney', 'human - male, 49 years old, Caucasian', '', '', '', '', 'Yes, in nude mice; forms clear cell carcinoma in nude mice consistent with renal primary; also forms tumors in steroid treated hamsters', 'Me-2,2;PGM3,1-2;PGM1,1;ES-D,1-2;AK-1,1;GLO-1,1-2;G6PD,B', '(P4)hypertriploid (+A2,+B,+C,+D,+E,+F,+G) with abnormalities', 'epithelial', '', '', 'monolayer', 'carcinoma, clear cell; metastasis to skin', 'carcinoma, clear cell; metastasis to skin', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'McCoy', 'Dulbecco', '', 'Remove medium, rinse with fresh 0.25% trypsin solution, remove trypsin and let the culture sit at room temperature (or at 37C) until the cells detach (about 10 min). Add fresh medium, aspirate and dispense into new flasks. Subculture every 6 to 8 days.', 'Fogh J et al. Absence of Hela cell contamination in 169 cell lines derived from human tumors. J.Natl.Cancer Inst. 58: 209-214, 1977Goodfellow M et al. One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J.Natl.Cacer Inst. 59: 221-226, 1977', '', '1608', '1:2 to 1:4', '2 to 3 times weekly');
INSERT INTO `cellbank_production` VALUES ('624', '10185', 'A549; A-549', 'Yes', '', 'lung', 'human - male, 58 years old,  Caucasian', '', '', '', 'negative', '', 'G6PD, B', '', 'epithelial', 'keratin', '', 'monolayer', 'carcinoma', 'carcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Ham', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', 'J Nat', 'the cells are positive for keratin by immunoperoxidase staining; the ampoules are labeled \"H549\"', '10967', '', '');
INSERT INTO `cellbank_production` VALUES ('625', '10120.1', 'CCRF-HSB-2; CCRF HSB-2; HSB-2', 'Yes', '', 'T cell; T lymphoblast', 'human - male, 11.5 years old,  Caucasian', '', '', '', '', 'yes, in syrian hamsters', 'G6PD, B', '', 'lymphoblast', '', '', 'suspension', 'leukemia, acute lymphoblastic', 'leukemia, acute lymphoblastic', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Iscove', 'Dulbecco���s Modified Eagle Medium, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', 'M.D. Anderson Hospital and Tumor Institue Monograph 21, 1967', 'derived from the same buffy coat preparation as KCLB 120 (CCRF-SB) by serially transplanting into newborn syrian hamsters.', '1368', '', '');
INSERT INTO `cellbank_production` VALUES ('626', '30054', 'Calu-1', 'Yes', '', 'lung; pleural effusion', 'human', '', '', '', '', '', '', '', '', '', '', 'adherent', 'epidermoid carcinoma; epithelial', 'epidermoid carcinoma; epithelial', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'McCoys 5a Medium Modified, 90%; fetal bovine serum (FBS), 10%', 'McCoys 5a Medium Modified, 90%; fetal bovine serum (FBS), 10%', '', '', '', 'Penicillin-streptomycin were added to culture media (final concentration, 100 U/mL)', '179', '', '');
INSERT INTO `cellbank_production` VALUES ('627', '21620', 'A172', 'Yes', '', 'brain', 'human - human', '', '', '', '', '', '', '', '', '', '', '', 'glioblastoma', 'glioblastoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Dulbecco', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', 'J Nat', '', '3732', '', '');
INSERT INTO `cellbank_production` VALUES ('628', '30080', 'Capan-2', 'Yes', '', 'pancreas', 'human - male, 56 years old, Caucasian', '', '', '', '', 'produces well-differentiated adenocarcinoma consistent with pancreatic carcinoma in nude mouse', 'Me-2, 2; PGM3, 2; PGM1, 1; ES D, 1; AK1, 1; G6PD, B; GLO-1, 2', '', 'epithelial', '', '', 'monolayer', 'adenocarcinoma', 'adenocarcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'McCoy', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', '', '', '1690', '', '');
INSERT INTO `cellbank_production` VALUES ('629', '10020.2', 'clone 1-5c-4; Wong-Kilbourne d', 'Yes', '', 'conjunctiva', 'human', '', 'poliovirus 1; vesicular stomatitis (Indiana); influenzaviruses A, B', '', 'negative', '', 'G6PD, A', '', 'epithelial', 'keratin', '', 'monolayer', 'normal', 'normal', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Medium 199 in Hanks\' BSS, 90%; heat inactivated bovine calf serum (BCS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', 'J Exp Med, 113:95, 1961', 'the cells are positive for keratin by immunoperoxidase staining; this cell line contains HeLa marker chromosomes and has type A G6PD (Ref.: Nature 259:211-213, 1976 and in Vitro 14:469-475, 1978)', '1458', '', '');
INSERT INTO `cellbank_production` VALUES ('630', '80003', 'A375P', 'Yes', '', '', 'human', '', '', '', '', '', '', '', '', '', '', 'monolayer', 'melanoma, low metastatic', 'melanoma, low metastatic', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Eagle\'s Minimum Essential Medium, 90%; heat inactivated fetal bovine serum (FBS), 10% or Dulbecco\'s modified Eagle\'s Medium, 90%, heat inactivated fetal bovine serum (FBS), 10%', 'Dulbecco\'s modified Eagle\'s Medium, 90%, heat inactivated fetal bovine serum (FBS), 10%', 'Isaiah J, Fidler', '', '', '', '3026', '', '');
INSERT INTO `cellbank_production` VALUES ('631', '10107', 'C6', 'Yes', '', 'glial cell', 'rat', '', 'vesicular stomatitis (Indiana); vaccinia; herpes simplex', 'poliovirus 3', 'negative', '', '', '', 'fibroblast', 'S-100 protein; produce glyceralphosphate dehydrogenase in response to glucocorticoids; somatotropin', '', 'monolayer', 'glioma', 'glioma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Ham\'s F10 medium, 82.5%; horse serum, 15%; FBS, 2.5%', 'Dulbecco\'s modified Eagle\'s medium, 90%; heat inactivated fetal bovine serum (FBS) 10%', '', '', 'Science, 161:370, 1968', 'S-100 production increases ten fold as cells grow from low density to confluency', '3078', '', '');
INSERT INTO `cellbank_production` VALUES ('632', '30079', 'Capan-1', 'Yes', '', 'pancreas', 'human - male, 40 years old, Caucasian', '', '', '', '', 'forms adenocarcinoma consistent with pancreatic duct carcinoma in nude mouse', 'Me-2, 1; PGM3, 1; PGM1, 1-2; ES D, 1; AK1, 1; G6PD, B; GLO-1, 1-2', '', 'epithelial', '', '', 'monolayer', 'adenocarcinoma; metastasis to liver', 'adenocarcinoma; metastasis to liver', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640, 85%; heat inactivated fetal bovine serum (FBS), 15%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', '', '', '2187', '', '');
INSERT INTO `cellbank_production` VALUES ('633', '10222', 'COLO 205', 'Yes', '', 'colon', 'human - male, 70 years old,  Caucasian', '', '', '', 'negative', 'yes, in nude mice', 'G6PD,B;PGM1,1-2;PGM3,1-2;6PDG,A;ES-D,1-2;PEP-D,1', '', 'epithelial', 'carcinoembryonic antigen(CEA) o.5ng/10exp6 cells/10days; keratin', '', 'cells grow loosely a', 'adenocarcinoma', 'adenocarcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', 'Cancer Res. 38:1345-1355, 1978', 'CSAp negative(CSAp-); the lines was derived from tissue from the same patient as COLO 201(KLCB 10221); the cells are positive for keratin by immunoperoxidase staining', '1542', '', '');
INSERT INTO `cellbank_production` VALUES ('634', '30037.1', 'Caco-2', 'Yes', '', 'colon', 'human - male, 72 years old, caucasian', '', '', '', '', '', '', '', 'epithelial', '', '', 'monolayer', 'adenocarcinoma', 'adenocarcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Minimum essential medium (Eagle) in Earle', 'Minimum essential medium, 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', 'Remove medium, add fresh 0.25 % trypsin 0.02 % EDTA solution, stand culture flask at 37', '', '', '5735', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('635', '21555', 'A-431', 'Yes', '', '', 'human - female, 85 years old', '', '', '', '', 'yes, in immunosuppressed mice', 'G6PD, B; PGM1, 1; PGM3, 1; ES-D, 1; Me-2, 0; AK-1, 1; GLO-1, 2', '', 'epithelial', '', '', 'monolayer', 'carcinoma, epidermoid', 'carcinoma, epidermoid', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Dulbecco', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', 'J Nat', '', '4194', '', '');
INSERT INTO `cellbank_production` VALUES ('636', '10119', 'CCRF-CEM; CCRF CEM', 'Yes', '', 'T cell; T lymphoblast', 'human - female, 4 years old, Caucasian', '', '', '', 'negative', 'yes, in syrian hamsters', 'G6PD, B', '', 'lymphoblast', '', 'CD3 B(37%), CD4(50%), CD5(95%), CD7(77%)', 'suspension', 'leukemia, acute lymphoblastic', 'leukemia, acute lymphoblastic', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640, 80%; heat inactivated fetal bovine serum (FBS), 20%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', 'Cancer, 18:522-529, 1965', '', '1957', '', '');
INSERT INTO `cellbank_production` VALUES ('637', '30055', 'Calu-3', 'Yes', '', 'lung', 'human - male, 25 years old, Caucasian', '', '', '', '', 'Yes, forms well differentiated grade I adenocarcinoma in nude mice', 'Me-2,1; PGM3, 1-2; PGM1,1; ES D, 1; AK1,1;GLO-1,1-2;G6PD,B', 'The stemline chromosome number is hypotriploid with the 2S component occurring at 1.4%', 'epithelial', '', '', 'monolayer', 'adenocarcinoma; pleural effusion', 'adenocarcinoma; pleural effusion', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Minimum essential medium (Eagle) in Earle', 'Dulbecco', '', 'Remove medium, add with fresh 0.25% trypsin solution for 1 min, remove trypsin and let the culture sit at room temperature for 5 to 10 mins. Add fresh medium, aspirate and dispense into new flasks.Subculture every 6 to 8 days', 'J.Fogh and G.Trempe, In: Human Tumor Cells In Vitro, PP.115-159, J. Fogh(ed), Plenum Press, New York, 1975. Fogh J et al. Absence of HeLa cell contamination in 169 cell lines derived from human tumors. J.Natl.Cancer Inst. 58: 209-214, 1977. Goodfellow M et al. One humdred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J.Natl.Cancer Inst. 59: 221-226, 1977', '', '1871', '1:3 to 1:6', '2 to 3 times per week');
INSERT INTO `cellbank_production` VALUES ('638', '30044', 'A-498', 'Yes', '', 'kidney', 'human - female, 52 years old', '', '', '', '', 'yes; in nude mice; forms undifferentiated carcinoma; also forms tumors in anti thymocyte serum treated newborn mice', 'PGM3, 1; PGM1, 1-2; ES-D, 2; Me-2, 1; AK-1, 1; GLO-1, 2; G6PD, B', '', 'epithelial', '', '', 'monolayer', 'carcinoma', 'carcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'MEM (Eagle) in Earle\'s BSS with non-essential amino acids and sodium pyruvate, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Dulbecco\'s modified Eagle\'s medium, 90%; heat inactivated fetal bovine serum (FBS) 10%', '', '', 'J Nat\'l Cancer Inst, 51;1417-1423, 1973', 'S. Aaronson isolated this line using techniques as described for KCLB 41', '2360', '', '');
INSERT INTO `cellbank_production` VALUES ('639', '21947', 'CCD-986sk', 'Yes', '', 'skin; fibroblast', 'human - human', '', '', '', '', '', '', '', 'fibroblast', '', '', 'monolayer', 'normal', 'normal', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'IMDM ; FBS,10%', 'IMDM ; FBS,10%', '', '', '', '', '10785', '', '');
INSERT INTO `cellbank_production` VALUES ('640', '30054.1G', 'Calu-1', 'Yes', '', 'lung; pleural effusion', 'human', '', '', '', '', '', '', '', '', '', '', 'adherent', 'epidermoid carcinoma; epithelial', 'epidermoid carcinoma; epithelial', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'McCoys 5a Medium Modified, 90%; fetal bovine serum (FBS), 10%', 'McCoys 5a Medium Modified, 90%; fetal bovine serum (FBS), 10%', '', '', '', '', '159', '', '');
INSERT INTO `cellbank_production` VALUES ('641', '80004', 'A375SM', 'Yes', '', '', 'human', '', '', '', '', '', '', '', '', '', '', '', 'melanoma, highly metastatic', 'melanoma, highly metastatic', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Eagle', 'Minimum Essential Medium, 90%, heat inactivated fetal bovine serum (FBS), 10%', 'Isaiah J, Fidler', '', '', '', '2747', '', '');
INSERT INTO `cellbank_production` VALUES ('642', '30076', 'Caov-4', 'Yes', '', 'ovary', 'human - female, 54 years, Caucasian', '', '', '', '', '', 'PGM3, 1; PGM1, 1; ES D, 1; AK1, 1; Me-2, 2; GLO-1, 1-2; G6PD, B', '', 'epithelial', '', '', 'monolayer', 'adenocarcinoma', 'adenocarcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Leibovitz', 'Leibovitz', '', '', '', '', '1469', '', '');
INSERT INTO `cellbank_production` VALUES ('643', '30046', 'Caki-1', 'Yes', '', 'kidney', 'human - male, 49 years old, Caucasian', '', '', '', '', 'Yes, in nude mice; forms clear cell carcinoma in nude mice consistent with renal primary; also forms tumors in steroid treated hamsters', 'Me-2,2;PGM3,1-2;PGM1,1;ES-D,1-2;AK-1,1;GLO-1,1-2;G6PD,B', '(P4)hypertriploid (+A2,+B,+C,+D,+E,+F,+G) with abnormalities', 'epithelial', '', '', 'monolayer', 'carcinoma, clear cell; metastasis to skin', 'carcinoma, clear cell; metastasis to skin', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'McCoy', 'Dulbecco', '', 'Remove medium, rinse with fresh 0.25% trypsin solution, remove trypsin and let the culture sit at room temperature (or at 37C) until the cells detach (about 10 min). Add fresh medium, aspirate and dispense into new flasks. Subculture every 6 to 8 days.', 'Fogh J et al. Absence of Hela cell contamination in 169 cell lines derived from human tumors. J.Natl.Cancer Inst. 58: 209-214, 1977Goodfellow M et al. One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J.Natl.Cacer Inst. 59: 221-226, 1977', '', '1608', '1:2 to 1:4', '2 to 3 times weekly');
INSERT INTO `cellbank_production` VALUES ('644', '80004', 'A375SM', 'Yes', '', '', 'human', '', '', '', '', '', '', '', '', '', '', '', 'melanoma, highly metastatic', 'melanoma, highly metastatic', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Eagle', 'Minimum Essential Medium, 90%, heat inactivated fetal bovine serum (FBS), 10%', 'Isaiah J, Fidler', '', '', '', '2747', '', '');
INSERT INTO `cellbank_production` VALUES ('645', '30076', 'Caov-4', 'Yes', '', 'ovary', 'human - female, 54 years, Caucasian', '', '', '', '', '', 'PGM3, 1; PGM1, 1; ES D, 1; AK1, 1; Me-2, 2; GLO-1, 1-2; G6PD, B', '', 'epithelial', '', '', 'monolayer', 'adenocarcinoma', 'adenocarcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Leibovitz', 'Leibovitz', '', '', '', '', '1469', '', '');
INSERT INTO `cellbank_production` VALUES ('646', '30055', 'Calu-3', 'Yes', '', 'lung', 'human - male, 25 years old, Caucasian', '', '', '', '', 'Yes, forms well differentiated grade I adenocarcinoma in nude mice', 'Me-2,1; PGM3, 1-2; PGM1,1; ES D, 1; AK1,1;GLO-1,1-2;G6PD,B', 'The stemline chromosome number is hypotriploid with the 2S component occurring at 1.4%', 'epithelial', '', '', 'monolayer', 'adenocarcinoma; pleural effusion', 'adenocarcinoma; pleural effusion', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Minimum essential medium (Eagle) in Earle', 'Dulbecco', '', 'Remove medium, add with fresh 0.25% trypsin solution for 1 min, remove trypsin and let the culture sit at room temperature for 5 to 10 mins. Add fresh medium, aspirate and dispense into new flasks.Subculture every 6 to 8 days', 'J.Fogh and G.Trempe, In: Human Tumor Cells In Vitro, PP.115-159, J. Fogh(ed), Plenum Press, New York, 1975. Fogh J et al. Absence of HeLa cell contamination in 169 cell lines derived from human tumors. J.Natl.Cancer Inst. 58: 209-214, 1977. Goodfellow M et al. One humdred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J.Natl.Cancer Inst. 59: 221-226, 1977', '', '1871', '1:3 to 1:6', '2 to 3 times per week');
INSERT INTO `cellbank_production` VALUES ('647', '30079', 'Capan-1', 'Yes', '', 'pancreas', 'human - male, 40 years old, Caucasian', '', '', '', '', 'forms adenocarcinoma consistent with pancreatic duct carcinoma in nude mouse', 'Me-2, 1; PGM3, 1; PGM1, 1-2; ES D, 1; AK1, 1; G6PD, B; GLO-1, 1-2', '', 'epithelial', '', '', 'monolayer', 'adenocarcinoma; metastasis to liver', 'adenocarcinoma; metastasis to liver', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640, 85%; heat inactivated fetal bovine serum (FBS), 15%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', '', '', '2187', '', '');
INSERT INTO `cellbank_production` VALUES ('648', '10053.1', 'Clone M-3; Cloudman S91 melano', 'Yes', '', 'melanocyte', 'mouse - male', '(C X DBA)F1', '', '', '', 'yes, in C57BL mice', '', '', 'epithelial', 'melanin', '', 'monolayer', 'melanoma; melanotic', 'melanoma; melanotic', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Ham\'s F10 medium, 82.5%; horse serum, 15%; FBS, 2.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', 'Science, 154:1186, 1966', 'tested and found negative for ectromelia virus (mousepox)', '2771', '', '');
INSERT INTO `cellbank_production` VALUES ('649', '10185', 'A549; A-549', 'Yes', '', 'lung', 'human - male, 58 years old,  Caucasian', '', '', '', 'negative', '', 'G6PD, B', '', 'epithelial', 'keratin', '', 'monolayer', 'carcinoma', 'carcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Ham', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', 'J Nat', 'the cells are positive for keratin by immunoperoxidase staining; the ampoules are labeled \"H549\"', '10967', '', '');
INSERT INTO `cellbank_production` VALUES ('650', '10223', 'CMT-93', 'Yes', '', 'rectum', 'mouse - male, 19 months old, Mus musculus', 'C57BL/icrf', '', '', 'positive', 'yes, in nude mice', '', '', 'epithelial', '', '', '', 'carcinoma, polyploid', 'carcinoma, polyploid', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Dulbecco\'s modified Eagle\'s medium with 4.5g/L glucose, 90%; heat inactivated fetal bovine serum (FBS), 10%- OR - bovine calf serum, 10%', 'Dulbecco\'s modified Eagle\'s medium, 90%; heat inactivated fetal bovine serum (FBS) 10%', '', 'remove medium , add fresh 0.25% trypsin solution for 2 to 4minutes, remove trypsin and let the culture sit at room temperature for 5 to 10 minutes, add fresh medium, aspirate and dispense into new flask', 'Franks LM and Hemmings VJ. A cell line from an induced carcinoma of mouse rectum. J. Pathol. 124: 35-38, 1978.', 'Tested and found negative for ectromelia virus (mousepox)', '842', '', '');
INSERT INTO `cellbank_production` VALUES ('651', '30045', 'A-704', 'Yes', '', 'kidney', 'human - male, 78 years old', '', '', '', '', 'No', 'Me-2,1;PGM3.1-2;PGM1,1;ES-D,1;AK-1,1;GLO-1,2;G6PD,B', '(P59) diploid to hyperdiploid, hypertriploid to hypertetraploid with abnormalities including breaks, dendritics and endoreduplication', 'epithelial', '', '', 'monolayer', 'adenocarcinoma', 'adenocarcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Minimum essential medium Eagle in Earle', 'Dulbecco', '', 'Remove medium, rinse with fresh 0.25% trypsin solution, remove trypsin and let the culture sit at room temperature (or at 37C) until the cells detach (about 10 min). Add fresh medium, aspirate and dispense into new flasks. Subculture every 6 to 8 days.', 'Giard DJ at al. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J.Natl.Cancer Inst. 51: 1417-1423, 1973', '', '1707', '1:3 to 1:4', '2 to 3 times weekly');
INSERT INTO `cellbank_production` VALUES ('652', '10220', 'COLO 320DM', 'Yes', '', 'colon', 'human - female, 55 years old, Caucasian', '', '', '', '', 'yes, in nude mouse', 'PGM1,1;PGM3,2;G6PD,B;PEP-D,1;6PDG,A;ES-D,1', '', 'rounded and refracti', 'serotonin; norepinephrine; epinephrine; adrenocorticotropic hormone(ACTH); parathyroid hormone', '', '', 'adenocarcinoma', 'adenocarcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', 'Cancer Res. 39: 4914-4924, 1979', 'cells grow loosely attached and in suspension', '882', '', '');
INSERT INTO `cellbank_production` VALUES ('653', '60051', 'AT-3.1', 'Yes', '', 'prostate', 'rat - Copenhagen', '', '', '', '', '', '', '', '', '', '', 'Suspension', 'carcinoma', 'carcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Prof. Untae Kim', '', 'For the more information for this cell line, please see the reference (metastasis-cell lines, Untaekim.pdf) uploaded in the KCLB web.', 'higly metastatic prostate carcinoma cell line', '1489', '', '');
INSERT INTO `cellbank_production` VALUES ('654', '10008', 'CCRF S-180 II', 'Yes', '', '', 'mouse - adult, Mus musculus', 'CFW', '', 'poliovirus 1', 'positive', 'yes, in CFW mice', '', '', 'fibroblast', '', '', 'monolayer', 'sarcoma', 'sarcoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Eagle\'s Minimum Essential Medium in Earle\'s BSS with non-essential amino acids, 95%; bovine calf serum (BCS), 5%', 'Dulbecco\'s modified Eagle\'s medium, 90%; heat inactivated fetal bovine serum (FBS) 10%', '', '', 'Cancer Res. 20:930, 1960', 'tested and found negative for ectromelia virus (mousepox)', '1480', '', '');
INSERT INTO `cellbank_production` VALUES ('655', '80005', 'A-431', 'Yes', '', '', 'human', '', '', '', '', '', '', '', '', '', '', 'monolayer', 'carcinoma, epidermoid', 'carcinoma, epidermoid', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Eagle', 'Minimum Essential Medium, 90%, heat inactivated fetal bovine serum (FBS), 10%', 'Isaiah J, Fidler', '', '', '', '3102', '', '');
INSERT INTO `cellbank_production` VALUES ('656', '10224', 'COLO 201', 'Yes', '', 'colon', 'human - male, 70 years old,  Caucasian', '', '', '', '', 'yes, in nude mice', 'G6PD,B;PGM1,1-2;PGM3,1-2;6PGD,A;ES-D,1-2;PEP-D,1', '', 'fibroblast like ; bi', '', '', 'cells grow loosely a', 'adenocarcinoma', 'adenocarcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 80%; heat inactivated fetal bovine serum (FBS), 20%', '', '', 'Cancer Res. 38:1345-1355, 1978', 'CSAp negative (CSAp-); CEA, negative; the line was derived from tissue from the same patient as COLO 205 (KCLB 222)', '1072', '', '');
INSERT INTO `cellbank_production` VALUES ('657', '88483', 'Anti-My-10 clone 28/8/8/14/4', 'Yes', '', 'hybridoma', 'mouse', '', '', '', '', '', '', '', 'lymphoblast-like', 'IgG1', '', 'suspension', '', '', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', 'Blood, 57:842-845, 1981', '', '1545', '', '');
INSERT INTO `cellbank_production` VALUES ('658', '21550', 'CaSki', 'Yes', '', 'cervix, uterine', 'human - female, 40 years old, Caucasian', '', '', '', '', '', 'G6PD, B', '', 'epithelial', 'beta subunit of human chorionic gonadotropin (hCG); tumor associated antigen', '', 'monolayer', 'carcinoma, epidermoid; metastasis', 'carcinoma, epidermoid; metastasis', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', 'Science, 196:1456-1458, 1977; J Virol, 61:962-971, 1987', 'the line was established from cells from a metastasis in the small bowel mesentery; the cells are reported to contain an integrated human papillomavirus type 16 genome (HPV-16, about 600 copies per cell)', '1355', '', '');
INSERT INTO `cellbank_production` VALUES ('659', '30080', 'Capan-2', 'Yes', '', 'pancreas', 'human - male, 56 years old, Caucasian', '', '', '', '', 'produces well-differentiated adenocarcinoma consistent with pancreatic carcinoma in nude mouse', 'Me-2, 2; PGM3, 2; PGM1, 1; ES D, 1; AK1, 1; G6PD, B; GLO-1, 2', '', 'epithelial', '', '', 'monolayer', 'adenocarcinoma', 'adenocarcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'McCoy', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', '', '', '1690', '', '');
INSERT INTO `cellbank_production` VALUES ('660', '80007', 'B16 F1', 'Yes', '', '', 'mouse', '', '', '', '', '', '', '', '', '', '', 'monolayer', 'melanoma', 'melanoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Dulbecco', 'Dulbecco\'s Modified Eagle medium, 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Isaiah J, Fidler', '', '', '', '3876', '', '');
INSERT INTO `cellbank_production` VALUES ('661', '10220.1', 'COLO 320 HSR', 'Yes', '', 'colon', 'human - female, 55 years old, Caucasian', '', '', '', 'negative', 'yes, in nude mice', 'PGM1, 1; PGM3, 2; G6PD, B; PEP-D, 1; 6PGD, A;ES-D, 1', 'marker chromosomes with homogeneously staining regions were observed and the double minute chromosomes appeared in much lower frequency than the parental line COLO 320DM', 'rounded and refracti', 'serotonin; norepinephrine; epinephrine; adrenocorticotropic hormone(ACTH); parathyroid hormone', '', 'The cells grows loos', 'adenocarcinoma; Dukes', 'adenocarcinoma; Dukes', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', 'Shake flask, pour one-half of the medium into a new flask and add fresh medium to both flasks. Cells remaining attached may be removed (if desired) using a standard trypsin protocol. Subculture once per week.', 'Clevenstine EC et al. Cell lines fromhuman colon carcinoma with unusual cell products, double minutes, and homogeneously staining regions. Cancer Res. 39: 4914-4924. 1979. Trainer DL et al. Biological characterization and oncogene expression in human colorectal carcinoma cell lines. Int. J. Cancer 41: 287-296, 1988', 'CEA(-), CSAp(-), colon antigen 3(+); This line is a subline of COLO 320DM (KCLB 10220). The cells are weakly positive for keratins and vimentin', '1090', '', '');
INSERT INTO `cellbank_production` VALUES ('662', '30075.1G', 'Caov-3', 'Yes', '', 'ovary; epithelial', 'human', '', '', '', '', '', '', '', '', '', '', 'adherent', 'adenocarcinoma', 'adenocarcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Dulbeccos Modified Eagles Medium, 90%; fetal bovine serum (FBS), 10%', 'Dulbeccos Modified Eagles Medium, 90%; fetal bovine serum (FBS), 10%', '', '', '', '', '182', '', '');
INSERT INTO `cellbank_production` VALUES ('663', '80008', 'B16 F10', 'Yes', '', '', 'mouse', '', '', '', '', '', '', '', '', '', '', 'monolayer', 'melanoma', 'melanoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Eagle', 'Dulbecco���s Modified Eagle���s Medium, 90%, heat inactivated fetal bovine serum (FBS), 10%', 'Isaiah J, Fidler', '', '', '', '6887', '', '');
INSERT INTO `cellbank_production` VALUES ('664', '10020.2', 'clone 1-5c-4; Wong-Kilbourne d', 'Yes', '', 'conjunctiva', 'human', '', 'poliovirus 1; vesicular stomatitis (Indiana); influenzaviruses A, B', '', 'negative', '', 'G6PD, A', '', 'epithelial', 'keratin', '', 'monolayer', 'normal', 'normal', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Medium 199 in Hanks\' BSS, 90%; heat inactivated bovine calf serum (BCS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', 'J Exp Med, 113:95, 1961', 'the cells are positive for keratin by immunoperoxidase staining; this cell line contains HeLa marker chromosomes and has type A G6PD (Ref.: Nature 259:211-213, 1976 and in Vitro 14:469-475, 1978)', '1458', '', '');
INSERT INTO `cellbank_production` VALUES ('665', '21739', 'AGS', 'Yes', '', 'stomach', 'human - female, 54 years old, Caucasian', '', '', '', '', 'yes, in athymic BALB/c mice', '', '', 'epithelial', '', '', 'monolayer', 'adenocarcinoma', 'adenocarcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Ham', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', 'Cancer Res, 43:1703-1709, 1983; Invest New Drugs, 1:117-127, 1983', 'the AGS cell line was derived from fragments of a tumor resected from a patient who had received no prior therapy; the cells have a plating efficiency of 34% in the medium below; the line was cured at the ATCC of a prior mycoplasma infection', '6572', '', '');
INSERT INTO `cellbank_production` VALUES ('666', '21459', 'CCD-18Co', 'Yes', '', 'colon', 'human - female, 2.5 months old, Black', '', '', '', '', '', '', '', 'fibroblast', '', '', 'monolayer', 'normal', 'normal', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'MEM (Eagle) in Earle', 'DMEM with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', 'Science 230:943-945', 'the line is at population doubling level(PDL)=22, and begins to senesce at about PDL=42; growth of the cells is enhanced by addition of tumor necrosis factor alpha (TNF alpha) to the medium', '2176', '', '');
INSERT INTO `cellbank_production` VALUES ('667', '10104', 'E.H. IV (Elanine IV)', 'Yes', '', 'B cell; B lymphoblast', 'human - female, 20 years old, Caucasian', '', '', 'partially resistant to poliovirus and vesicular stomatitis viruses', 'negative', '', 'G6PD, B', '', 'lymphoblast', 'Epstein-Barr virus (EBV)', '', 'suspension', 'infectious mononucleosis', 'infectious mononucleosis', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640, 80%; heat inactivated fetal bovine serum (FBS), 20%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', 'Proc Nat', 'The cells carry and produce Epstein-Barr virus (EBV); EBNA positive; Biological Safety Class II', '1006', '', '');
INSERT INTO `cellbank_production` VALUES ('668', '88483', 'Anti-My-10 clone 28/8/8/14/4', 'Yes', '', 'hybridoma', 'mouse', '', '', '', '', '', '', '', 'lymphoblast-like', 'IgG1', '', 'suspension', '', '', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', 'Blood, 57:842-845, 1981', '', '1545', '', '');
INSERT INTO `cellbank_production` VALUES ('669', '21213', 'FR', 'Yes', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', '', '', '', '', '', '', '153', '', '');
INSERT INTO `cellbank_production` VALUES ('670', '60050', 'AT-2.1', 'Yes', '', 'prostate', 'rat - Copenhagen', '', '', '', '', '', '', '', '', '', '', '', 'carcinoma', 'carcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Prof. Untae Kim', '', 'For the more information for this cell line, please see the reference (metastasis-cell lines, Untaekim.pdf) uploaded in the KCLB web.', 'low or non-metastatic prostate carcinoma cell line', '1647', '', '');
INSERT INTO `cellbank_production` VALUES ('671', '60050', 'AT-2.1', 'Yes', '', 'prostate', 'rat - Copenhagen', '', '', '', '', '', '', '', '', '', '', '', 'carcinoma', 'carcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Prof. Untae Kim', '', 'For the more information for this cell line, please see the reference (metastasis-cell lines, Untaekim.pdf) uploaded in the KCLB web.', 'low or non-metastatic prostate carcinoma cell line', '1647', '', '');
INSERT INTO `cellbank_production` VALUES ('672', '40039', 'EL4', 'Yes', '', 'T cell; T lymphocyte', 'mouse', 'C57BL', '', '', '', '', '', '', 'lymphoblast', '', 'H-2b; Thy-1.2', 'suspension', 'lymphoma', 'lymphoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Dulbecco\'s modified Eagle\'s Medium, 90%; horse serum, 10%', 'Dulbecco\'s modified Eagle\'s medium, 80%; heat inactivated fetal bovine serum (FBS) 20%', '', '', 'British J Cancer, 4:372-379, 1950; Cancer Res, 25:813-819, 1965; J Immunol, 108:1146-1151, 1972, J Nat\'l Cancer Inst, 48:265-271, 1972; J Immunol, 110:1470-1475, 1973; J Nat\'l Cancer Inst, 51:883-890, 1973', 'established from a lymphoma induced in a C57BL mouse by 9,10-dimethyl-1,2-benzanthracene; the cells are resistant to 0.1mM cortisol and sensitive to 20 mcg/ml PHA; a subline (EL4IL-2, KCLB 400181) that produces high levels of interleukin-2 (IL-2, interleukin 2) is available; tested and found negative for ectromelia virus (mousepox)', '3265', '', '');
INSERT INTO `cellbank_production` VALUES ('673', '9S1187.1G', 'HCC-1187', 'Yes', '', 'breast', 'human', '', '', '', '', '', '', '', '', '', '', 'adherent and suspens', 'primary ductal carcinoma; epithelial', 'primary ductal carcinoma; epithelial', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; fetal bovine serum (FBS), 10%', '', '', '', '', '157', '', '');
INSERT INTO `cellbank_production` VALUES ('674', '60049', 'B-23', 'Yes', '', 'brain', 'rat - BD-1X rat', '', '', '', '', '', '', '', '', '', '', '', 'astrocytoma', 'astrocytoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Prof. Untae Kim', '', 'For the more information for this cell line, please see the reference (metastasis-cell lines, Untaekim.pdf) uploaded in the KCLB web.', '', '2115', '', '');
INSERT INTO `cellbank_production` VALUES ('675', '21891', 'FB2', 'Yes', '', 'B cell; B lymphocyte', 'mouse', 'RBF/DnJ (B cell); BALB/c (myeloma)', '', '', '', '', 'IgG3; kappa light chain', '', 'lymphoblast', 'immunoglobulin; monoclonal antibody; against phosphotyrosine', '', 'suspension', 'hybridoma; mouse(myeloma)', 'hybridoma; mouse(myeloma)', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with 10mM HEPES, 0.039mg/ml thymidine, 176 ng/ml aminopterin, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', 'J Biol Chem, 259:7909-7915, 1984', 'spleen cells were fused with FOX-NY myeloma cells; the antibody reacts with several phosphorylated proteins on Western blots and in immunoprecipitation reactions; thymidine and aminopterin are added to the culture medium to stabilize the presence of the immunoglobulin heavy chain locus', '1447', '', '');
INSERT INTO `cellbank_production` VALUES ('676', '9S1143', 'HCC-1143', 'Yes', '', 'breast', 'human', '', '', '', '', '', '', '', 'Epithelial', '', '', 'adherent', '', '', '', '', '', 'Gazdar', '', 'Int J Cancer. 1998 Dec 9;78(6):766-74.', '', '32', '', '');
INSERT INTO `cellbank_production` VALUES ('677', '10120', 'CCRF-SB', 'Yes', '', 'B cell; B lymphocyte', 'human - male, 11.5 years old,  caucasian', '', '', '', 'negative', '', 'G6PD, B', '', 'lymphoblast', '', 'HLA A1, A2, B12, B17, Cw2', 'suspension', 'acute lymphoblastic leukemia', 'acute lymphoblastic leukemia', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640, 90%; bovine calf serum (BCS), 10% or Iscove', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', 'M.D. Anderson Hospital and Tumor Institue Monograph 21, 1967', 'derived from a buffy coat preparation from a patient with ALL; a T cell line (HSB-2, CCL 120.1) was also obtained from the same buffy coat preparation; the cells are EBNA positve.', '257', '', '');
INSERT INTO `cellbank_production` VALUES ('678', '10044', 'EBTr (NBL-4)', 'Yes', '', 'trachea', 'bovine - male, embryo', 'Bos taurus', 'bovine viral diarrhea; infectious bovine rhinotracheitis; parainfluenzavirus 3; herpes simplex; reovirus 3; vesicular stomatitis (Oghen); vaccinia', 'human adenovirus 5; poliovirus 2; coxsackievirus A9, B5', 'negative', '', '', '', 'fibroblast', '', '', 'monolayer', 'normal', 'normal', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'MEM in Earle\'s BSS with non-essential amino acids and Earle\'s BSS, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Dulbecco\'s modified Eagle\'s medium, 90%; heat inactivated fetal bovine serum (FBS) 10%', '', '', '', '', '825', '', '');
INSERT INTO `cellbank_production` VALUES ('679', '60049', 'B-23', 'Yes', '', 'brain', 'rat - BD-1X rat', '', '', '', '', '', '', '', '', '', '', '', 'astrocytoma', 'astrocytoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Prof. Untae Kim', '', 'For the more information for this cell line, please see the reference (metastasis-cell lines, Untaekim.pdf) uploaded in the KCLB web.', '', '2115', '', '');
INSERT INTO `cellbank_production` VALUES ('680', '10061', 'CHO-K1', 'Yes', '', 'ovary', 'hamster - female; Chinese hamster', 'Cricetulus griseus', 'vesicular stomatitis(Indiana); Getah virus', 'poliovirus 2; modoc virus; Button Willow virus', 'negative', '', '', '20', 'epithelial', '', '', 'monolayer', 'normal', 'normal', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Ham\'s F12 medium, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', 'J Exp Med, 108:945, 1958', 'The cells require proline for growth', '4599', '', '');
INSERT INTO `cellbank_production` VALUES ('681', '21720', 'F9', 'Yes', '', 'testis', 'mouse - male', '129', '', '', '', '', '', '', 'epithelial', 'plasminogen activator; laminin; type IV collagen', '', 'monolayer', 'teratoma, testicular; embryonal carcinoma', 'teratoma, testicular; embryonal carcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Dulbecco\'s modified Eagle\'s Medium, with 4.5g/L glucose, 85%; heat inactivated fetal bovine serum (FBS), 15%', 'Dulbecco\'s modified Eagle\'s medium, 90%; heat inactivated fetal bovine serum (FBS) 10%', '', '', 'Cell, 15:393-403, 1978', 'F9 cells can be stimulated to differentiate into parietal endoderm in the presence of retinoic acid and dibutyryl cyclic AMP (cAMP); differentiating cells synthesize plasminogen activator, laminin and type IV collagen; cAMP is active only on cells that have been treated with retinoic acid; tested and found negative for ectromelia virus (mousepox); culture vessels must be coated with 0.1% gelatin prior to use. To do so, cover the surface to of the vessel with 0.1% gelatin (Difco) in sterile distilled water for 2 hours at 4C, then wash three times with sterile distilled water. Treated flasks and', '1113', '', '');
INSERT INTO `cellbank_production` VALUES ('682', '30043', 'FaDu', 'Yes', '', 'pharynx', 'human - male, 56 years old, Caucasian', '', '', '', '', 'Yes, in nude mice; forms well differentiated epidermoid carcinoma (grade I)', 'Me-2,2;PGM3,1;PGM1,2;ES-D,1;AK-1,1;GLO-1,2;G6PD,B', '(P16) hypodiploid to hypertriploid', 'epithelial', '', '', 'monolayer', 'carcinoma, squamous cell', 'carcinoma, squamous cell', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Minimum essential medium (Eagle) in Earle', 'Eagle', '', 'Remove medium, rinse with fresh 0.25% trypsin solution, remove trypsin and let the culture sit at room temperature (or at 37C) until the cells detach (about 10 min). Add fresh medium, aspirate and dispense into new flasks. Subculture every 6 to 8 days.', 'Fogh J et al. Absence of Hela cell contamination in 169 cell lines derived from human tumors. J.Natl.Cancer Inst. 58: 209-214, 1977Goodfellow M et al. One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J.Natl.Cacer Inst. 59: 221-226, 1977Rangan SR. A new human cell line (FaDu) from a hypopharyngeal carcinoma. Cancer 29: 117-121, 1972', 'The line was found to contain bundles of tonofilaments in the cell cytoplasm and desmosomal regions were prominent at cell boundaries.', '940', '1:2 to 1:4', '2 to 3 times weekly');
INSERT INTO `cellbank_production` VALUES ('683', '9S1569', 'HCC-1569', 'Yes', '', 'breast', 'human - female, 70 years old, black', '', '', '', '', '', '', '', 'epithelial', '', '', 'monolayer', 'metastatic cancer', 'metastatic cancer', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Adi F Gazdar', 'Remove medium, add fresh 0.25 % trypsin 0.02 % EDTA solution, stand culture flask at 37', 'Gazdar et al., Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer, Int J Cancer, 1998, 78:766-774', '', '658', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('684', '71171', 'HCC-1171', 'Yes', '', 'lung', 'human - male, 58 years old', '', '', '', '', '', '', '', 'epithelial', '', '', 'monolayer', 'adenocarcinoma', 'adenocarcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Gazdar AF', 'Remove medium, add fresh 0.25 % trypsin 0.02 % EDTA solution, stand culture flask at 37\'C for 3 to 5 minutes, add culture medium and collect the cells, transfer the medium into 15ml tube, centrifuge, aspirate the medium, resuspend the pellets with culture medium and dispense into the culture flask', 'Wistuba II et al., Comparison of features of human lung cancer cell lines and their corresponding tumors, Clin Cancer Res, 1999, 5:991-1000', '', '1462', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('685', '30043', 'FaDu', 'Yes', '', 'pharynx', 'human - male, 56 years old, Caucasian', '', '', '', '', 'Yes, in nude mice; forms well differentiated epidermoid carcinoma (grade I)', 'Me-2,2;PGM3,1;PGM1,2;ES-D,1;AK-1,1;GLO-1,2;G6PD,B', '(P16) hypodiploid to hypertriploid', 'epithelial', '', '', 'monolayer', 'carcinoma, squamous cell', 'carcinoma, squamous cell', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Minimum essential medium (Eagle) in Earle', 'Eagle', '', 'Remove medium, rinse with fresh 0.25% trypsin solution, remove trypsin and let the culture sit at room temperature (or at 37C) until the cells detach (about 10 min). Add fresh medium, aspirate and dispense into new flasks. Subculture every 6 to 8 days.', 'Fogh J et al. Absence of Hela cell contamination in 169 cell lines derived from human tumors. J.Natl.Cancer Inst. 58: 209-214, 1977Goodfellow M et al. One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J.Natl.Cacer Inst. 59: 221-226, 1977Rangan SR. A new human cell line (FaDu) from a hypopharyngeal carcinoma. Cancer 29: 117-121, 1972', 'The line was found to contain bundles of tonofilaments in the cell cytoplasm and desmosomal regions were prominent at cell boundaries.', '940', '1:2 to 1:4', '2 to 3 times weekly');
INSERT INTO `cellbank_production` VALUES ('686', '71569', 'HCC-1569', 'Yes', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', '', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Gazdar AF', '', '', '', '1047', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('687', '9S0202', 'HCC-202', 'Yes', '', 'breast', 'human - female, 82 years old, white', '', '', '', '', '', '', '', 'epithelial', '', '', 'monolayer', 'ductal cancer', 'ductal cancer', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Adi F Gazdar', 'Remove medium, add fresh 0.25 % trypsin 0.02 % EDTA solution, stand culture flask at 37', 'Gazdar et al., Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer, Int J Cancer, 1998, 78:766-774', '', 'epithelial', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('688', '80012', 'DX3', 'Yes', '', '', 'human', '', '', '', '', '', '', '', '', '', '', 'monolayer', 'melanoma', 'melanoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Eagle\'s Minimum Essential Medium, 90%; heat inactivated fetal bovine serum (FBS), 10% or Dulbecco\'s modified Eagle\'s Medium, 90%, heat inactivated fetal bovine serum (FBS), 10%', 'Eagle\'s Minimum Essential Medium, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Isaiah J, Fidler', '', '', '', '1231', '', '');
INSERT INTO `cellbank_production` VALUES ('689', '9S1599', 'HCC-1599', 'Yes', '', 'breast, mammary gland; epithelial, lymphoblast', 'human', '', '', '', '', '', '', '', '', '', '', 'suspension, aggregat', '', '', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; fetal bovine serum (FBS), 10%', 'Adi F. Gazdar', '', 'Int J Cancer. 1998 Dec 9;78(6):766-74.', 'Penicillin-streptomycin were added to culture media (final concentration, 100 U/mL)', '227', '', '');
INSERT INTO `cellbank_production` VALUES ('690', '9S1739BL', 'HCC-1739BL', 'Yes', '', 'B cell; matched B lymphoblastoid cell line of HCC-1739', 'human - female, 51 years old, white', '', '', '', '', '', '', '', 'lymphoblastoid', '', '', 'suspension', 'Epstein-Barr virus transformed', 'Epstein-Barr virus transformed', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Adi F Gazdar', 'Collect the cell in the 15ml tube, centrifuge, remove medium and add fresh medium', 'Gazdar et al., Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer, Int J Cancer, 1998, 78:766-774', '', 'lymphoblastoid', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('691', '30081', 'DU 145', 'Yes', '', 'prostate', 'human - male, 69 years old, Caucasian', '', '', '', '', 'forms adenocarcinoma, grade II consistent with prostatic primary', 'Me-2, 1-2; PGM3, 2; PGM1, 1; ES D, 1; AK1, 1; G6PD, B; GLO-1,2', '', 'epithelial', '', '', 'monolayer', 'carcinoma, metastasis to brain', 'carcinoma, metastasis to brain', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Eagle', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', '', '', '2438', '', '');
INSERT INTO `cellbank_production` VALUES ('692', '40195', 'CEM-CM3', 'Yes', '', 'T cell; T lymphoblast', 'human - female, 4 years old, Caucasian', '', '', '', '', '', '', '', 'lymphoblast', 'this line was derived from CCRF-CEM by selecting for resistance to 8-azaguanine; the line has been used as a fusion partner in the production of human-human T cell hybridomas', '', 'suspension', 'leukemia, acute lymphoblastic', 'leukemia, acute lymphoblastic', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with 15 mcg/ml 8-azaguanine, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Dulbecco\'s modified Eagle\'s medium, 90%; heat inactivated fetal bovine serum (FBS) 10%', '', '', 'Clin Res, 31:734A, 1983; Cathcart, M.K. and M. Murakami, Nonspecific suppression of antibody synthesis by products of human T lymphocyte hybridomas. Use of a newly selected parent fusion line. In: T cell Hybrodomas (M.J. Taussig, ed.) CRC press, Boca Raton, FL. 1985 p. 227-236; Cathcart, M.K. Human T Lymphocyte hybridomas: Production of nonspecific suppressor factors of antibody synthesis. 5th International Congress of Immunology, Kyoto, Japna, August, 1983, Abstract', 'this line was derived from CCRF-CEM by selecting for resistance to 8-azaguanine; the line has been used as a fusion partner in the production of human-human T cell hybridomas', '1179', '', '');
INSERT INTO `cellbank_production` VALUES ('693', '9S1428BL', 'HCC-1428BL', 'Yes', '', 'B cell; matched B lymphoblastoid cell line of HCC-1428', 'human - female, 49 years old, white', '', '', '', '', '', '', '', 'lymphoblastoid', '', '', 'suspension', 'Epstein-Barr virus transformed', 'Epstein-Barr virus transformed', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Adi F Gazdar', 'Collect the cell in the 15ml tube, centrifuge, remove medium and add fresh medium', 'Gazdar et al., Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer, Int J Cancer, 1998, 78:766-774', '', 'lymphoblastoid', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('694', '71833', 'HCC-1833', 'Yes', '', 'lung', 'human', '', '', '', '', '', '', '', 'epithelial', '', '', 'monolayer', 'adenocarcinoma', 'adenocarcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', '', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Gazdar AF', '', '', '', '1253', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('695', '71588', 'HCC-1588', 'Yes', '', 'lung', 'human - female, 63 years old', '', '', '', '', '', '', '', 'epithelial', '', '', 'monolayer', 'squamous cell carcinoma', 'squamous cell carcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Gazdar AF', 'Remove medium, add fresh 0.25 % trypsin 0.02 % EDTA solution, stand culture flask at 37', 'Wistuba II et al., Comparison of features of human lung cancer cell lines and their corresponding tumors, Clin Cancer Res, 1999, 5:991-1000', '', '1281', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('696', '10224', 'COLO 201', 'Yes', '', 'colon', 'human - male, 70 years old,  Caucasian', '', '', '', '', 'yes, in nude mice', 'G6PD,B;PGM1,1-2;PGM3,1-2;6PGD,A;ES-D,1-2;PEP-D,1', '', 'fibroblast like ; bi', '', '', 'cells grow loosely a', 'adenocarcinoma', 'adenocarcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 80%; heat inactivated fetal bovine serum (FBS), 20%', '', '', 'Cancer Res. 38:1345-1355, 1978', 'CSAp negative (CSAp-); CEA, negative; the line was derived from tissue from the same patient as COLO 205 (KCLB 222)', '1072', '', '');
INSERT INTO `cellbank_production` VALUES ('697', '9S1187.1G', 'HCC-1187', 'Yes', '', 'breast', 'human', '', '', '', '', '', '', '', '', '', '', 'adherent and suspens', 'primary ductal carcinoma; epithelial', 'primary ductal carcinoma; epithelial', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; fetal bovine serum (FBS), 10%', '', '', '', '', '157', '', '');
INSERT INTO `cellbank_production` VALUES ('698', '9S1187BL', 'HCC-1187BL', 'Yes', '', 'B cell; matched B lymphoblastoid cell line of HCC-1197', 'human - female, 41 years old, white', '', '', '', '', '', '', '', 'lymphoblastoid', '', '', 'suspension', 'Epstein-Barr virus transformed', 'Epstein-Barr virus transformed', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Adi F Gazdar', 'Collect the cell in the 15ml tube, centrifuge, remove medium and add fresh medium', 'Gazdar et al., Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer, Int J Cancer, 1998, 78:766-774', '', 'lymphoblastoid', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('699', '9S1143', 'HCC-1143', 'Yes', '', 'breast', 'human', '', '', '', '', '', '', '', 'Epithelial', '', '', 'adherent', '', '', '', '', '', 'Gazdar', '', 'Int J Cancer. 1998 Dec 9;78(6):766-74.', '', '32', '', '');
INSERT INTO `cellbank_production` VALUES ('700', '71359', 'HCC-1359', 'Yes', '', 'lung', 'human - female, 55 years old', '', '', '', '', '', '', '', 'epithelial', '', '', 'monolayer', 'spindle-giant cell tumor', 'spindle-giant cell tumor', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Gazdar AF', 'Remove medium, add fresh 0.25 % trypsin 0.02 % EDTA solution, stand culture flask at 37\'C for 3 to 5 minutes, add culture medium and collect the cells, transfer the medium into 15ml tube, centrifuge, aspirate the medium, resuspend the pellets with culture medium and dispense into the culture flask', 'Wistuba II et al., Comparison of features of human lung cancer cell lines and their corresponding tumors, Clin Cancer Res, 1999, 5:991-1000', '', '857', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('701', '10044', 'EBTr (NBL-4)', 'Yes', '', 'trachea', 'bovine - male, embryo', 'Bos taurus', 'bovine viral diarrhea; infectious bovine rhinotracheitis; parainfluenzavirus 3; herpes simplex; reovirus 3; vesicular stomatitis (Oghen); vaccinia', 'human adenovirus 5; poliovirus 2; coxsackievirus A9, B5', 'negative', '', '', '', 'fibroblast', '', '', 'monolayer', 'normal', 'normal', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'MEM in Earle\'s BSS with non-essential amino acids and Earle\'s BSS, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Dulbecco\'s modified Eagle\'s medium, 90%; heat inactivated fetal bovine serum (FBS) 10%', '', '', '', '', '825', '', '');
INSERT INTO `cellbank_production` VALUES ('702', '9S2157BL', 'HCC-2157BL', 'Yes', '', 'B cell; matched B lymphoblastoid cell line of HCC-2157', 'human - female, 48 years old, black', '', '', '', '', '', '', '', 'lymphoblastoid', '', '', 'suspension', 'Epstein-Barr virus transformed', 'Epstein-Barr virus transformed', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Adi F Gazdar', 'Collect the cell in the 15ml tube, centrifuge, remove medium and add fresh medium', 'Gazdar et al., Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer, Int J Cancer, 1998, 78:766-774', '', '449', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('703', '9S0202', 'HCC-202', 'Yes', '', 'breast', 'human - female, 82 years old, white', '', '', '', '', '', '', '', 'epithelial', '', '', 'monolayer', 'ductal cancer', 'ductal cancer', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Adi F Gazdar', 'Remove medium, add fresh 0.25 % trypsin 0.02 % EDTA solution, stand culture flask at 37', 'Gazdar et al., Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer, Int J Cancer, 1998, 78:766-774', '', 'epithelial', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('704', '71171', 'HCC-1171', 'Yes', '', 'lung', 'human - male, 58 years old', '', '', '', '', '', '', '', 'epithelial', '', '', 'monolayer', 'adenocarcinoma', 'adenocarcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Gazdar AF', 'Remove medium, add fresh 0.25 % trypsin 0.02 % EDTA solution, stand culture flask at 37\'C for 3 to 5 minutes, add culture medium and collect the cells, transfer the medium into 15ml tube, centrifuge, aspirate the medium, resuspend the pellets with culture medium and dispense into the culture flask', 'Wistuba II et al., Comparison of features of human lung cancer cell lines and their corresponding tumors, Clin Cancer Res, 1999, 5:991-1000', '', '1462', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('705', '71438', 'HCC-1438', 'Yes', '', 'lung', 'human - male, 43 years old', '', '', '', '', '', '', '', 'epithelial', '', '', 'monolayer', 'large cell tumor', 'large cell tumor', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Gazdar AF', 'Remove medium, add fresh 0.25 % trypsin 0.02 % EDTA solution, stand culture flask at 37', 'Wistuba II et al., Comparison of features of human lung cancer cell lines and their corresponding tumors, Clin Cancer Res, 1999, 5:991-1000', '', '948', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('706', '70366', 'HCC-366', 'Yes', '', 'lung', 'human', '', '', '', '', '', '', '', '', '', '', '', 'NSCLC, non small cell lung cancer', 'NSCLC, non small cell lung cancer', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', '', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Gazdar AF', '', 'Cancer Res., 64, 4277-4285', '', '1364', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('707', '30081', 'DU 145', 'Yes', '', 'prostate', 'human - male, 69 years old, Caucasian', '', '', '', '', 'forms adenocarcinoma, grade II consistent with prostatic primary', 'Me-2, 1-2; PGM3, 2; PGM1, 1; ES D, 1; AK1, 1; G6PD, B; GLO-1,2', '', 'epithelial', '', '', 'monolayer', 'carcinoma, metastasis to brain', 'carcinoma, metastasis to brain', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Eagle', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', '', '', '2438', '', '');
INSERT INTO `cellbank_production` VALUES ('708', '9S1599.1G', 'HCC-1599', 'Yes', '', 'breast, mammary gland; epithelial, lymphoblast', 'human', '', '', '', '', '', '', '', '', '', '', 'suspension, aggregat', '', '', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; fetal bovine serum (FBS), 10%', '', '', 'Int J Cancer. 1998 Dec 9;78(6):766-74.', '', '163', '', '');
INSERT INTO `cellbank_production` VALUES ('709', '9S1428', 'HCC-1428', 'Yes', '', 'breast', 'human - female, 49 years old, white', '', '', '', '', '', '', '', 'epithelial', '', '', 'monolayer', 'metastatic adenocarcinoma', 'metastatic adenocarcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Adi F Gazdar', 'Remove medium, add fresh 0.25 % trypsin 0.02 % EDTA solution, stand culture flask at 37', 'Gazdar et al., Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer, Int J Cancer, 1998, 78:766-774', '', 'epithelial', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('710', '9S1187BL', 'HCC-1187BL', 'Yes', '', 'B cell; matched B lymphoblastoid cell line of HCC-1197', 'human - female, 41 years old, white', '', '', '', '', '', '', '', 'lymphoblastoid', '', '', 'suspension', 'Epstein-Barr virus transformed', 'Epstein-Barr virus transformed', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Adi F Gazdar', 'Collect the cell in the 15ml tube, centrifuge, remove medium and add fresh medium', 'Gazdar et al., Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer, Int J Cancer, 1998, 78:766-774', '', 'lymphoblastoid', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('711', '72108', 'HCC-2108', 'Yes', '', 'lung', 'human - male, 59 years old', '', '', '', '', '', '', '', 'epithelial', '', '', 'monolayer', 'adenocarcinoma', 'adenocarcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Gazdar AF', 'Remove medium, add fresh 0.25 % trypsin 0.02 % EDTA solution, stand culture flask at 37', 'Wistuba II et al., Comparison of features of human lung cancer cell lines and their corresponding tumors, Clin Cancer Res, 1999, 5:991-1000', '', '1033', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('712', '9S1143.1G', 'HCC-1143', 'Yes', '', 'breast', 'human', '', '', '', '', '', '', '', 'Epithelial', '', '', 'adherent', '', '', '', '', '', '', '', 'Int J Cancer. 1998 Dec 9;78(6):766-74.', '', '30', '', '');
INSERT INTO `cellbank_production` VALUES ('713', '72373', 'HCC-2373', 'Yes', '', 'lung', 'human - male', '', '', '', '', '', '', '', '', '', '', '', '', '', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Gazdar AF', 'Remove medium, add fresh 0.25 % trypsin 0.02 % EDTA solution, stand culture flask at 37\'C for 3 to 5 minutes, add culture medium and collect the cells, transfer the medium into 15ml tube, centrifuge, aspirate the medium, resuspend the pellets with culture medium and dispense into the culture flask', 'Wistuba II et al., Comparison of features of human lung cancer cell lines and their corresponding tumors, Clin Cancer Res, 1999, 5:991-1000', '', '786', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('714', '9S1008.1G', 'HCC-1008', 'Yes', '', 'breast', 'human', '', '', '', '', '', '', '', 'Epithelial', '', '', '', '', '', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'HITES medium; Fetal bovine serum (FBS), 10%', 'HITES medium; Fetal bovine serum (FBS), 10%', '', '', 'Int J Cancer. 1998 Dec 9;78(6):766-74.', '', 'HITES medium; F', '', '');
INSERT INTO `cellbank_production` VALUES ('715', '72108', 'HCC-2108', 'Yes', '', 'lung', 'human - male, 59 years old', '', '', '', '', '', '', '', 'epithelial', '', '', 'monolayer', 'adenocarcinoma', 'adenocarcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Gazdar AF', 'Remove medium, add fresh 0.25 % trypsin 0.02 % EDTA solution, stand culture flask at 37', 'Wistuba II et al., Comparison of features of human lung cancer cell lines and their corresponding tumors, Clin Cancer Res, 1999, 5:991-1000', '', '1033', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('716', '9S1187', 'HCC-1187', 'Yes', '', 'breast', 'human', '', '', '', '', '', '', '', '', '', '', 'adherent and suspens', 'primary ductal carcinoma; epithelial', 'primary ductal carcinoma; epithelial', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; fetal bovine serum (FBS), 10%', '', '', '', 'Penicillin-streptomycin were added to culture media (final concentration, 100 U/mL)', '151', '', '');
INSERT INTO `cellbank_production` VALUES ('717', '72373', 'HCC-2373', 'Yes', '', 'lung', 'human - male', '', '', '', '', '', '', '', '', '', '', '', '', '', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Gazdar AF', 'Remove medium, add fresh 0.25 % trypsin 0.02 % EDTA solution, stand culture flask at 37\'C for 3 to 5 minutes, add culture medium and collect the cells, transfer the medium into 15ml tube, centrifuge, aspirate the medium, resuspend the pellets with culture medium and dispense into the culture flask', 'Wistuba II et al., Comparison of features of human lung cancer cell lines and their corresponding tumors, Clin Cancer Res, 1999, 5:991-1000', '', '786', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('718', '9S1395', 'HCC-1395', 'Yes', '', 'breast, mammary gland', 'human - female, 23 years old, caucacian', '', '', '', '', '', '', 'polyploid; extensive rearrangements in chromosome 1, 3, 9, 11, and 17', 'epithelial', 'Epithelial glycoprotein 2 (EGP2)', '', 'monolayer', 'ductal cancer', 'ductal cancer', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 95%; heat inactivated fetal bovine serum (FBS), 5%', 'Adi F Gazdar', 'Remove medium, add fresh 0.25 % trypsin 0.02 % EDTA solution, stand culture flask at 37\'C for 3 to 5 minutes, add culture medium and collect the cells, transfer the medium into 15ml tube, centrifuge, aspirate the medium, resuspend the pellets with culture medium and dispense into the culture flask', 'Gazdar et al., Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer, Int J Cancer, 1998, 78:766-774, Tomlinson GE et al. Characterization of paired and non-tumor cell lines established from patients with breast cancer. Cancer Res. 58: 3237-3242, 1998.', 'Oncogene : BRCA1 mutation, insertion C at nucleotide 5382, Her2/neu(-), p53(+). This line grows as large epithelial cells with a tendency to float at high cell densities. BRCA1 analysis revealed that the cell line is homozygous for the BRCA1 5382C mutation, whereas the lymphoblastoid cell line derived from the same patient is heterozygous for the same mutation. This mutation was present in tow other family members; an identical sister also developed breast cancer. The cell line has an acquired mutation of TP53 with wild-type allele loss; an acquired homozygous deletion of the PTEN gene, and lo', '1552', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('719', '70033', 'HCC-33', 'Yes', '', 'Lung', 'human', '', '', '', '', '', '', '', '', '', '', '', 'SCLC, small cell lung cancer', 'SCLC, small cell lung cancer', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', '', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Gazdar AF', '', 'Cancer Res., 64, 4277-4285', '', '1234', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('720', '9S1428', 'HCC-1428', 'Yes', '', 'breast', 'human - female, 49 years old, white', '', '', '', '', '', '', '', 'epithelial', '', '', 'monolayer', 'metastatic adenocarcinoma', 'metastatic adenocarcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Adi F Gazdar', 'Remove medium, add fresh 0.25 % trypsin 0.02 % EDTA solution, stand culture flask at 37', 'Gazdar et al., Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer, Int J Cancer, 1998, 78:766-774', '', 'epithelial', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('721', '71359', 'HCC-1359', 'Yes', '', 'lung', 'human - female, 55 years old', '', '', '', '', '', '', '', 'epithelial', '', '', 'monolayer', 'spindle-giant cell tumor', 'spindle-giant cell tumor', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Gazdar AF', 'Remove medium, add fresh 0.25 % trypsin 0.02 % EDTA solution, stand culture flask at 37\'C for 3 to 5 minutes, add culture medium and collect the cells, transfer the medium into 15ml tube, centrifuge, aspirate the medium, resuspend the pellets with culture medium and dispense into the culture flask', 'Wistuba II et al., Comparison of features of human lung cancer cell lines and their corresponding tumors, Clin Cancer Res, 1999, 5:991-1000', '', '857', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('722', '9S0038BL', 'HCC-38BL', 'Yes', '', 'B cell; matched B lymphoblastoid cell line of HCC-38', 'human - female, 50 years old, white', '', '', '', '', '', '', '', 'lymphoblastoid', '', '', 'suspension', 'Epstein-Barr virus transformed', 'Epstein-Barr virus transformed', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Adi F Gazdar', 'Collect the cell in the 15ml tube, centrifuge, remove medium and add fresh medium', 'Gazdar et al., Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer, Int J Cancer, 1998, 78:766-774', '', 'lymphoblastoid', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('723', '71719', 'HCC-1719', 'Yes', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', '', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Gazdar AF', '', '', '', '1002', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('724', '9S1599', 'HCC-1599', 'Yes', '', 'breast, mammary gland; epithelial, lymphoblast', 'human', '', '', '', '', '', '', '', '', '', '', 'suspension, aggregat', '', '', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; fetal bovine serum (FBS), 10%', 'Adi F. Gazdar', '', 'Int J Cancer. 1998 Dec 9;78(6):766-74.', 'Penicillin-streptomycin were added to culture media (final concentration, 100 U/mL)', '227', '', '');
INSERT INTO `cellbank_production` VALUES ('725', '71195', 'HCC-1195', 'Yes', '', 'lung', 'human - male, 47 years old', '', '', '', '', '', '', '', 'epithelial', '', '', 'monolayer', 'adeno-squamous cell carcinoma', 'adeno-squamous cell carcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Gazdar AF', 'Remove medium, add fresh 0.25 % trypsin 0.02 % EDTA solution, stand culture flask at 37', 'Wistuba II et al., Comparison of features of human lung cancer cell lines and their corresponding tumors, Clin Cancer Res, 1999, 5:991-1000', '', '1094', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('726', '9S1937', 'HCC-1937', 'Yes', '', 'breast', 'human - female, 24 years old, white', '', '', '', '', '', '', '', 'epithelial', '', '', 'monolayer', 'ductal cancer', 'ductal cancer', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Adi F Gazdar', 'Remove medium, add fresh 0.25 % trypsin 0.02 % EDTA solution, stand culture flask at 37', 'Gazdar et al., Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer, Int J Cancer, 1998, 78:766-774', '', 'epithelial', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('727', '9S2185', 'HCC-2185', 'Yes', '', 'breast', 'human - female, 49 years old, Caucasian', '', '', '', '', '', '', '', '', '', '', 'non-adherent', 'metastatic lobular carcinoma', 'metastatic lobular carcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'ACL4 medium with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 95%; heat inactivated fetal bovine serum (FBS), 5%', 'ACL4 medium with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 95%; heat inactivated fetal bovine serum (FBS), 5%', 'Adi F. Gazdar', '', 'Gazdar et al., Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer, Int J Cancer, 1998, 78:766-774', '', '842', '', '');
INSERT INTO `cellbank_production` VALUES ('728', '9S1395BL', 'HCC-1395BL', 'Yes', '', 'B cell; matched B lymphoblastoid cell line of HCC-1395', 'human - female, 24 years old, caucacian', '', '', '', '', '', '', '', 'lymphoblastoid', '', '', 'suspension', 'Epstein-Barr virus transformed', 'Epstein-Barr virus transformed', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Adi F Gazdar', 'Collect the cell in the 15ml tube, centrifuge, remove medium and add fresh medium', 'Gazdar et al., Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer, Int J Cancer, 1998, 78:766-774, Tomlinson GE et al. Characterization of paired and non-tumor cell lines established from patients with breast cancer. Cancer Res. 58: 3237-3242, 1998.', 'Oncogene : BRCA1 mutation, insertion C at nucleotide 5382 ; The cells grow as floating aggregates of large cell clusters.This line is a B lymphoblastoid cell line initiated by Epstein-Barr virus (EBV) transformation of peripheral blood lymphocytes obtained from the same patient as SCC-1395 ( a primary breast ductal carcinoma cell line). BRCA1 analysis revealed that this cell line is heterozygous for the BRCA1 5382C mutation, whereas the primary tumor cell line is homozygous for the same mutation.', '1239', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('729', '9S1954BL', 'HCC-1954BL', 'Yes', '', 'B cell; matched B lymphoblastoid cell line of HCC-1954', 'human - female, 61 years old, east indian', '', '', '', '', '', '', '', 'lymphoblastoid', '', '', 'suspension', 'Epstein-Barr virus transformed', 'Epstein-Barr virus transformed', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Adi F Gazdar', 'Collect the cell in the 15ml tube, centrifuge, remove medium and add fresh medium', 'Gazdar et al., Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer, Int J Cancer, 1998, 78:766-774', '', '583', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('730', '9S1187', 'HCC-1187', 'Yes', '', 'breast', 'human', '', '', '', '', '', '', '', '', '', '', 'adherent and suspens', 'primary ductal carcinoma; epithelial', 'primary ductal carcinoma; epithelial', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; fetal bovine serum (FBS), 10%', '', '', '', 'Penicillin-streptomycin were added to culture media (final concentration, 100 U/mL)', '151', '', '');
INSERT INTO `cellbank_production` VALUES ('731', '9S2218', 'HCC-2218', 'Yes', '', 'breast', 'human - female, 38 years old, white', '', '', '', '', '', '', '', 'epithelial', '', '', 'suspension, floating', 'ductal cancer', 'ductal cancer', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Adi F Gazdar', 'Remove medium, add fresh 0.25 % trypsin 0.02 % EDTA solution, stand culture flask at 37', 'Gazdar et al., Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer, Int J Cancer, 1998, 78:766-774', '', 'epithelial', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('732', '9S1599BL', 'HCC-1599BL', 'Yes', '', 'B cell; matched B lymphoblastoid cell line of HCC-1599', 'human - female, 70 years old, black', '', '', '', '', '', '', '', 'lymphoblastoid', '', '', 'suspension', 'Epstein-Barr virus transformed', 'Epstein-Barr virus transformed', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Adi F Gazdar', 'Collect the cell in the 15ml tube, centrifuge, remove medium and add fresh medium', 'Gazdar et al., Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer, Int J Cancer, 1998, 78:766-774', '', '660', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('733', '9S1395', 'HCC-1395', 'Yes', '', 'breast, mammary gland', 'human - female, 23 years old, caucacian', '', '', '', '', '', '', 'polyploid; extensive rearrangements in chromosome 1, 3, 9, 11, and 17', 'epithelial', 'Epithelial glycoprotein 2 (EGP2)', '', 'monolayer', 'ductal cancer', 'ductal cancer', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 95%; heat inactivated fetal bovine serum (FBS), 5%', 'Adi F Gazdar', 'Remove medium, add fresh 0.25 % trypsin 0.02 % EDTA solution, stand culture flask at 37\'C for 3 to 5 minutes, add culture medium and collect the cells, transfer the medium into 15ml tube, centrifuge, aspirate the medium, resuspend the pellets with culture medium and dispense into the culture flask', 'Gazdar et al., Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer, Int J Cancer, 1998, 78:766-774, Tomlinson GE et al. Characterization of paired and non-tumor cell lines established from patients with breast cancer. Cancer Res. 58: 3237-3242, 1998.', 'Oncogene : BRCA1 mutation, insertion C at nucleotide 5382, Her2/neu(-), p53(+). This line grows as large epithelial cells with a tendency to float at high cell densities. BRCA1 analysis revealed that the cell line is homozygous for the BRCA1 5382C mutation, whereas the lymphoblastoid cell line derived from the same patient is heterozygous for the same mutation. This mutation was present in tow other family members; an identical sister also developed breast cancer. The cell line has an acquired mutation of TP53 with wild-type allele loss; an acquired homozygous deletion of the PTEN gene, and lo', '1552', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('734', '9S1599.1G', 'HCC-1599', 'Yes', '', 'breast, mammary gland; epithelial, lymphoblast', 'human', '', '', '', '', '', '', '', '', '', '', 'suspension, aggregat', '', '', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; fetal bovine serum (FBS), 10%', '', '', 'Int J Cancer. 1998 Dec 9;78(6):766-74.', '', '163', '', '');
INSERT INTO `cellbank_production` VALUES ('735', '9S1143.1G', 'HCC-1143', 'Yes', '', 'breast', 'human', '', '', '', '', '', '', '', 'Epithelial', '', '', 'adherent', '', '', '', '', '', '', '', 'Int J Cancer. 1998 Dec 9;78(6):766-74.', '', '30', '', '');
INSERT INTO `cellbank_production` VALUES ('736', '9S1937BL', 'HCC-1937BL', 'Yes', '', 'B cell; matched B lymphoblastoid cell line of HCC-1937', 'human - female, 24 years old, white', '', '', '', '', '', '', '', 'lymphoblastoid', '', '', 'suspension', 'Epstein-Barr virus transformed', 'Epstein-Barr virus transformed', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Adi F Gazdar', 'Collect the cell in the 15ml tube, centrifuge, remove medium and add fresh medium', 'Gazdar et al., Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer, Int J Cancer, 1998, 78:766-774', '', 'lymphoblastoid', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('737', '9S1954', 'HCC-1954', 'Yes', '', 'breast', 'human - female, 61 years old, east indian', '', '', '', '', '', '', '', 'epithelial', '', '', 'monolayer', 'ductal cancer', 'ductal cancer', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Adi F Gazdar', 'Remove medium, add fresh 0.25 % trypsin 0.02 % EDTA solution, stand culture flask at 37\'C for 3 to 5 minutes, add culture medium and collect the cells, transfer the medium into 15ml tube, centrifuge, aspirate the medium, resuspend the pellets with culture medium and dispense into the culture flask', 'Gazdar et al., Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer, Int J Cancer, 1998, 78:766-774', '', '938', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('738', '10104', 'E.H. IV (Elanine IV)', 'Yes', '', 'B cell; B lymphoblast', 'human - female, 20 years old, Caucasian', '', '', 'partially resistant to poliovirus and vesicular stomatitis viruses', 'negative', '', 'G6PD, B', '', 'lymphoblast', 'Epstein-Barr virus (EBV)', '', 'suspension', 'infectious mononucleosis', 'infectious mononucleosis', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640, 80%; heat inactivated fetal bovine serum (FBS), 20%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', 'Proc Nat', 'The cells carry and produce Epstein-Barr virus (EBV); EBNA positive; Biological Safety Class II', '1006', '', '');
INSERT INTO `cellbank_production` VALUES ('739', '72279', 'HCC-2279', 'Yes', '', 'lung', 'human - female, 52 years old', '', '', '', '', '', '', '', 'epithelial', '', '', 'monolayer', 'adeno-squamous cell carcinoma', 'adeno-squamous cell carcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Gazdar AF', 'Remove medium, add fresh 0.25 % trypsin 0.02 % EDTA solution, stand culture flask at 37', 'Wistuba II et al., Comparison of features of human lung cancer cell lines and their corresponding tumors, Clin Cancer Res, 1999, 5:991-1000', '', '1013', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('740', '9S1954', 'HCC-1954', 'Yes', '', 'breast', 'human - female, 61 years old, east indian', '', '', '', '', '', '', '', 'epithelial', '', '', 'monolayer', 'ductal cancer', 'ductal cancer', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Adi F Gazdar', 'Remove medium, add fresh 0.25 % trypsin 0.02 % EDTA solution, stand culture flask at 37\'C for 3 to 5 minutes, add culture medium and collect the cells, transfer the medium into 15ml tube, centrifuge, aspirate the medium, resuspend the pellets with culture medium and dispense into the culture flask', 'Gazdar et al., Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer, Int J Cancer, 1998, 78:766-774', '', '938', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('741', '21720', 'F9', 'Yes', '', 'testis', 'mouse - male', '129', '', '', '', '', '', '', 'epithelial', 'plasminogen activator; laminin; type IV collagen', '', 'monolayer', 'teratoma, testicular; embryonal carcinoma', 'teratoma, testicular; embryonal carcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Dulbecco\'s modified Eagle\'s Medium, with 4.5g/L glucose, 85%; heat inactivated fetal bovine serum (FBS), 15%', 'Dulbecco\'s modified Eagle\'s medium, 90%; heat inactivated fetal bovine serum (FBS) 10%', '', '', 'Cell, 15:393-403, 1978', 'F9 cells can be stimulated to differentiate into parietal endoderm in the presence of retinoic acid and dibutyryl cyclic AMP (cAMP); differentiating cells synthesize plasminogen activator, laminin and type IV collagen; cAMP is active only on cells that have been treated with retinoic acid; tested and found negative for ectromelia virus (mousepox); culture vessels must be coated with 0.1% gelatin prior to use. To do so, cover the surface to of the vessel with 0.1% gelatin (Difco) in sterile distilled water for 2 hours at 4C, then wash three times with sterile distilled water. Treated flasks and', '1113', '', '');
INSERT INTO `cellbank_production` VALUES ('742', '70044', 'HCC-44', 'Yes', '', 'lung', '', '', '', '', '', '', '', '', '', '', '', '', 'NSCLC, non small cell lung cancer', 'NSCLC, non small cell lung cancer', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', '', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Gazdar AF', '', 'Cancer Res., 64, 4277-4285', '', '1117', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('743', '9S1599BL', 'HCC-1599BL', 'Yes', '', 'B cell; matched B lymphoblastoid cell line of HCC-1599', 'human - female, 70 years old, black', '', '', '', '', '', '', '', 'lymphoblastoid', '', '', 'suspension', 'Epstein-Barr virus transformed', 'Epstein-Barr virus transformed', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Adi F Gazdar', 'Collect the cell in the 15ml tube, centrifuge, remove medium and add fresh medium', 'Gazdar et al., Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer, Int J Cancer, 1998, 78:766-774', '', '660', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('744', '71438', 'HCC-1438', 'Yes', '', 'lung', 'human - male, 43 years old', '', '', '', '', '', '', '', 'epithelial', '', '', 'monolayer', 'large cell tumor', 'large cell tumor', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Gazdar AF', 'Remove medium, add fresh 0.25 % trypsin 0.02 % EDTA solution, stand culture flask at 37', 'Wistuba II et al., Comparison of features of human lung cancer cell lines and their corresponding tumors, Clin Cancer Res, 1999, 5:991-1000', '', '948', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('745', '9S0038', 'HCC-38', 'Yes', '', 'breast', 'human - female, 50 years old, white', '', '', '', '', '', '', '', 'epithelial', '', '', 'monolayer', 'ductal cancer', 'ductal cancer', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 95%; heat inactivated fetal bovine serum (FBS), 5%', 'Adi F Gazdar', 'Remove medium, add fresh 0.25 % trypsin 0.02 % EDTA solution, stand culture flask at 37', 'Gazdar et al., Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer, Int J Cancer, 1998, 78:766-774', '', 'epithelial', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('746', '70095', 'HCC-95', 'Yes', '', 'lung', 'human - male, 65 years old', '', '', '', '', '', '', '', 'epithelial', '', '', 'monolayer', 'squamous cell carcinoma', 'squamous cell carcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Gazdar AF', 'Remove medium, add fresh 0.25 % trypsin 0.02 % EDTA solution, stand culture flask at 37', 'Wistuba II et al., Comparison of features of human lung cancer cell lines and their corresponding tumors, Clin Cancer Res, 1999, 5:991-1000', '', '1383', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('747', '9S1954BL', 'HCC-1954BL', 'Yes', '', 'B cell; matched B lymphoblastoid cell line of HCC-1954', 'human - female, 61 years old, east indian', '', '', '', '', '', '', '', 'lymphoblastoid', '', '', 'suspension', 'Epstein-Barr virus transformed', 'Epstein-Barr virus transformed', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Adi F Gazdar', 'Collect the cell in the 15ml tube, centrifuge, remove medium and add fresh medium', 'Gazdar et al., Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer, Int J Cancer, 1998, 78:766-774', '', '583', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('748', '80012', 'DX3', 'Yes', '', '', 'human', '', '', '', '', '', '', '', '', '', '', 'monolayer', 'melanoma', 'melanoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Eagle\'s Minimum Essential Medium, 90%; heat inactivated fetal bovine serum (FBS), 10% or Dulbecco\'s modified Eagle\'s Medium, 90%, heat inactivated fetal bovine serum (FBS), 10%', 'Eagle\'s Minimum Essential Medium, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Isaiah J, Fidler', '', '', '', '1231', '', '');
INSERT INTO `cellbank_production` VALUES ('749', '70015', 'HCC-15', 'Yes', '', 'Lung', 'human', '', '', '', '', '', '', '', '', '', '', '', 'NSCLC, non small cell lung cancer', 'NSCLC, non small cell lung cancer', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', '', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Gazdar AF', '', 'Cancer Res, 64:4277-4285, 2004', '', '1418', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('750', '9S0038', 'HCC-38', 'Yes', '', 'breast', 'human - female, 50 years old, white', '', '', '', '', '', '', '', 'epithelial', '', '', 'monolayer', 'ductal cancer', 'ductal cancer', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 95%; heat inactivated fetal bovine serum (FBS), 5%', 'Adi F Gazdar', 'Remove medium, add fresh 0.25 % trypsin 0.02 % EDTA solution, stand culture flask at 37', 'Gazdar et al., Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer, Int J Cancer, 1998, 78:766-774', '', 'epithelial', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('751', '10247', 'HCT 116', 'Yes', '', 'colon; colorectal', 'human - male', '', '', '', 'negative', 'yes, in nude mice', 'G6PD, B; PGM1, 1; PGM3, 1; ES-D, 1-2; AK-1, 1; GLO-1, 1', '', 'epithelial', 'carcinoembryonic antigen (CEA) 1 ng per 10exp6 cells per 10 days; keratin', '', 'monolayer', 'carcinoma', 'carcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'McCoy', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', 'Cancer Res, 41:1751-1756, 1981', 'the cells are positive for keratin by immunoperoxidase staining; growth and plating efficiency are enhanced by using a feeder layer of murine fibroblasts', '5728', '', '');
INSERT INTO `cellbank_production` VALUES ('752', '9S1937BL', 'HCC-1937BL', 'Yes', '', 'B cell; matched B lymphoblastoid cell line of HCC-1937', 'human - female, 24 years old, white', '', '', '', '', '', '', '', 'lymphoblastoid', '', '', 'suspension', 'Epstein-Barr virus transformed', 'Epstein-Barr virus transformed', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Adi F Gazdar', 'Collect the cell in the 15ml tube, centrifuge, remove medium and add fresh medium', 'Gazdar et al., Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer, Int J Cancer, 1998, 78:766-774', '', 'lymphoblastoid', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('753', '70366', 'HCC-366', 'Yes', '', 'lung', 'human', '', '', '', '', '', '', '', '', '', '', '', 'NSCLC, non small cell lung cancer', 'NSCLC, non small cell lung cancer', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', '', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Gazdar AF', '', 'Cancer Res., 64, 4277-4285', '', '1364', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('754', '10002', 'HeLa', 'Yes', '', 'cervix, uterine', 'human - female, 31 years old; Black', '', 'poliovirus 1,2,3; adenovirus 3, encephalomyocarditis; coxsachievirus B serotypes', '', 'negative', '', 'G6PD, A', '', 'epithelial', 'keratin', '', 'monolayer', 'adenocarcinoma', 'adenocarcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Eagle', 'Minimum Essential Medium, 90%, heat inactivated fetal bovine serum (FBS), 10%', '', '', 'Cancer Res. 12:264, 1952; Cytonent Cell Genet, 48:19-24, 1988', 'the cells are positive for keratin by immunoperoxidase staining', '10395', '', '');
INSERT INTO `cellbank_production` VALUES ('755', '9S1739BL', 'HCC-1739BL', 'Yes', '', 'B cell; matched B lymphoblastoid cell line of HCC-1739', 'human - female, 51 years old, white', '', '', '', '', '', '', '', 'lymphoblastoid', '', '', 'suspension', 'Epstein-Barr virus transformed', 'Epstein-Barr virus transformed', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Adi F Gazdar', 'Collect the cell in the 15ml tube, centrifuge, remove medium and add fresh medium', 'Gazdar et al., Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer, Int J Cancer, 1998, 78:766-774', '', 'lymphoblastoid', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('756', '22026', 'Hepa-1c1c7', 'Yes', '', 'liver', 'mouse - Mus musculus', 'C57L', '', '', '', '', '', '', 'epithelial', 'cytochrome P450IA1', '', 'monolayer', 'Hepatoma', 'Hepatoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Alpha minimum essential medium without nucleosides, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'minimum essential medium 90%; heat inactivated fetal bovine serum (FBS), 10%', '', 'Remove medium, add fresh 0.25% trypsin, 0.03% EDTA solution and let the culture sit at room temperature for 3 minutes. Remove the trypsin and allow the culture to sit an additional 5 minutes until they begin to detach. Add fresh medium, aspirate and dispense into new flasks.', 'Bernhard HP et al. Expression of liver phenotypes in cultured mouse hepatoma cells: synthesis and secretion of serum albumin. Dev.Biol. 35: 83-96, 1973. Hankinson O et al. Genetic and molecular analysis of the Ah receptor and of Cyp1a1 gene expression. Biochimie 73: 61-66, 1991. Hankinson O. Single-step selection of clones of a mouse hepatoma line deficient in aryl hydrocarbon hydroxylase. Proc.Natl.Acad.Sci.USA 76: 373-376, 1979', '', '3371', '1:4 to 1:10', 'twice weekly');
INSERT INTO `cellbank_production` VALUES ('757', '88064', 'Hep3B', 'Yes', '', 'liver', 'human', '', '', '', '', '', '', '', 'epithelial', '', '', 'monolayer', 'carcinoma, hepatocellular', 'carcinoma, hepatocellular', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Medium Eagle', 'DMEM Medium ; heat inactivated fetal bovine serum (FBS), 10%', '', '', 'Nature, 282:615, 1979', 'HBV infected, HBV surface antigen secretion', '6475', '', '');
INSERT INTO `cellbank_production` VALUES ('758', '71588', 'HCC-1588', 'Yes', '', 'lung', 'human - female, 63 years old', '', '', '', '', '', '', '', 'epithelial', '', '', 'monolayer', 'squamous cell carcinoma', 'squamous cell carcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Gazdar AF', 'Remove medium, add fresh 0.25 % trypsin 0.02 % EDTA solution, stand culture flask at 37', 'Wistuba II et al., Comparison of features of human lung cancer cell lines and their corresponding tumors, Clin Cancer Res, 1999, 5:991-1000', '', '1281', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('759', '9S2185', 'HCC-2185', 'Yes', '', 'breast', 'human - female, 49 years old, Caucasian', '', '', '', '', '', '', '', '', '', '', 'non-adherent', 'metastatic lobular carcinoma', 'metastatic lobular carcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'ACL4 medium with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 95%; heat inactivated fetal bovine serum (FBS), 5%', 'ACL4 medium with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 95%; heat inactivated fetal bovine serum (FBS), 5%', 'Adi F. Gazdar', '', 'Gazdar et al., Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer, Int J Cancer, 1998, 78:766-774', '', '842', '', '');
INSERT INTO `cellbank_production` VALUES ('760', '10002.2', 'HeLa S3', 'Yes', '', 'cervix, uterine', 'human - female, 31 years old; Black', '', 'poliovirus 1,2,3; vesicular stomatitis (Indiana); encephalocarditis; adenovirus 5', '', 'negative', '', 'G6PD, A', '', 'epithelial', 'keratin', '', 'monolayer', 'adenocarcinoma', 'adenocarcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Ham\'s F12 medium, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', 'J Exp Med, 103:273-284, 1956; Cytogenet Cell Genet, 48:19-24, 1988', 'this cell line can be adapted to grow in suspension; the cells are positive for keratin by immunoperoxidase staining', '2732', '', '');
INSERT INTO `cellbank_production` VALUES ('761', '9S1419', 'HCC-1419', 'Yes', '', 'breast', 'human - female, 42 years old, hispanic', '', '', '', '', '', '', '', 'epithelial', '', '', 'monolayer', 'ductal cancer', 'ductal cancer', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Adi F Gazdar', 'Remove medium, add fresh 0.25 % trypsin 0.02 % EDTA solution, stand culture flask at 37', 'Gazdar et al., Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer, Int J Cancer, 1998, 78:766-774', '', '890', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('762', '70966', 'HCC-966', 'Yes', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', '', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Gazdar AF', '', '', '', '1114', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('763', '9S2157BL', 'HCC-2157BL', 'Yes', '', 'B cell; matched B lymphoblastoid cell line of HCC-2157', 'human - female, 48 years old, black', '', '', '', '', '', '', '', 'lymphoblastoid', '', '', 'suspension', 'Epstein-Barr virus transformed', 'Epstein-Barr virus transformed', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Adi F Gazdar', 'Collect the cell in the 15ml tube, centrifuge, remove medium and add fresh medium', 'Gazdar et al., Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer, Int J Cancer, 1998, 78:766-774', '', '449', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('764', '10002.1', 'HeLa 229', 'Yes', '', 'cervix, uterine', 'human - female, 31 years old; Black', '', 'vesicular stomatitis (Indiana); adenovirus 3', 'poliovirus 1,2,3', 'negative', '', 'G6PD, A', '', 'epithelial', 'keratin', '', 'monolayer', 'adenocarcinoma', 'adenocarcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Eagle', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', 'Scherer in 1952', 'This cells can be adapted to growth in suspension.; relatively resistant to polioviruses.; positive for keratin by immunoperoxidases staining', '3052', '', '');
INSERT INTO `cellbank_production` VALUES ('765', '9S1569', 'HCC-1569', 'Yes', '', 'breast', 'human - female, 70 years old, black', '', '', '', '', '', '', '', 'epithelial', '', '', 'monolayer', 'metastatic cancer', 'metastatic cancer', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Adi F Gazdar', 'Remove medium, add fresh 0.25 % trypsin 0.02 % EDTA solution, stand culture flask at 37', 'Gazdar et al., Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer, Int J Cancer, 1998, 78:766-774', '', '658', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('766', '70033', 'HCC-33', 'Yes', '', 'Lung', 'human', '', '', '', '', '', '', '', '', '', '', '', 'SCLC, small cell lung cancer', 'SCLC, small cell lung cancer', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', '', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Gazdar AF', '', 'Cancer Res., 64, 4277-4285', '', '1234', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('767', '88064', 'Hep3B', 'Yes', '', 'liver', 'human', '', '', '', '', '', '', '', 'epithelial', '', '', 'monolayer', 'carcinoma, hepatocellular', 'carcinoma, hepatocellular', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Medium Eagle', 'DMEM Medium ; heat inactivated fetal bovine serum (FBS), 10%', '', '', 'Nature, 282:615, 1979', 'HBV infected, HBV surface antigen secretion', '6475', '', '');
INSERT INTO `cellbank_production` VALUES ('768', '72279', 'HCC-2279', 'Yes', '', 'lung', 'human - female, 52 years old', '', '', '', '', '', '', '', 'epithelial', '', '', 'monolayer', 'adeno-squamous cell carcinoma', 'adeno-squamous cell carcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Gazdar AF', 'Remove medium, add fresh 0.25 % trypsin 0.02 % EDTA solution, stand culture flask at 37', 'Wistuba II et al., Comparison of features of human lung cancer cell lines and their corresponding tumors, Clin Cancer Res, 1999, 5:991-1000', '', '1013', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('769', '22190', 'HK-2', 'Yes', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', '', 'RPMI1640, 90%; FBS, 10%', '', '', '', '', '921', '', '');
INSERT INTO `cellbank_production` VALUES ('770', '70015', 'HCC-15', 'Yes', '', 'Lung', 'human', '', '', '', '', '', '', '', '', '', '', '', 'NSCLC, non small cell lung cancer', 'NSCLC, non small cell lung cancer', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', '', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Gazdar AF', '', 'Cancer Res, 64:4277-4285, 2004', '', '1418', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('771', '27701', 'HF282.Sp', 'Yes', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', '', '', '', '', '', '', '117', '', '');
INSERT INTO `cellbank_production` VALUES ('772', '9S1428BL', 'HCC-1428BL', 'Yes', '', 'B cell; matched B lymphoblastoid cell line of HCC-1428', 'human - female, 49 years old, white', '', '', '', '', '', '', '', 'lymphoblastoid', '', '', 'suspension', 'Epstein-Barr virus transformed', 'Epstein-Barr virus transformed', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Adi F Gazdar', 'Collect the cell in the 15ml tube, centrifuge, remove medium and add fresh medium', 'Gazdar et al., Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer, Int J Cancer, 1998, 78:766-774', '', 'lymphoblastoid', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('773', '21777', 'HIT-T15', 'No', '', 'pancreas; islet of Langerhans; beta cell', 'hamster - hamster', 'Syrian golden', '', '', '', '', '', '', 'epithelial', 'insulin', '', 'monolayer', '', '', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Ham\'s F 12K medium with 2mM  L-glutamine adjusted to contain 1.5g/L sodium bicarbonate, 87.5%; dialyzed horse serum, 10%; heat inactivated fetal bovine serum (FBS), 2.5 %', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', 'Remove medium, add fresh 0.25 % trypsin (enough to cover the monolayer) and let stand at room temperature until the cells detach. Add fresh medium, aspirate and dispense into new flasks at about 1.3 X exp5 cells per sq.cm.', 'Lord JM and Ashcroft SJ. Identification and chracterization of Ca2+ phospholipid-dependent protein kinase in rat islet and hamster beta-cells. Biochem. J. 219: 547-551, 1984.', 'This line was established from a primary culture of Syrian hamster islet cells which were transformed with SV40.The cells secrete up to 24ng of insulin in per 10 exp6 cells per 24 hours(passage 60).Insulin in secretion is stimulated by glucose and glucagon, and is suppressed by somatostatin and glucocorticoids.Insulin synthesis decreases with length of time in culture.', 'No', '', '');
INSERT INTO `cellbank_production` VALUES ('774', '27648', 'HS903.SK', 'Yes', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', '', '', '', '', '', '', '1065', '', '');
INSERT INTO `cellbank_production` VALUES ('775', '21589', 'IEC-18', 'Yes', '', 'ileum; epithelial', 'rat', '', '', '', '', '', '', '', 'epithelial', '', '', 'monolayer', 'normal', 'normal', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Dulbecco', 'DMEM 90%; fetal bovine serum (FBS), 10%', '', 'Remove medium, rinse monolayer with  fresh 0.25 % trypsin, 0.02 M EDTA solution, remove trypsin, add fresh medium, aspirate and dispense into new flasks.', 'Quaroni A et al. Epithelioid cell cultures from rat small intestine. Characterization by morphologic and immunologic criteria. J Cell Biol. 80: 248-265, 1979. Quaroni A and Isselbacher HJ. Cytotoxic effects and metabolism of benzopyrene and 7,12 - dimethylbenzanthracene in duodenal and ileal epithelial cell cultures. J. Natl. Cancer Inst. 67: 1353-1362, 1981.', '', '1668', '', '');
INSERT INTO `cellbank_production` VALUES ('776', '30040', 'HUTU 80', 'Yes', '', 'duodenum', 'human - male, 53 years old, Caucasian', '', '', '', '', 'Yes, in nude mice; forms well differentiated papillary adenocarcinoma, (grade I).', 'PGM3,1-2;PGM1,1-2;ES-D,1;Me-2,2;AK-1,1;GLO-1,2;G6PD,B', '(P12) hypodiploid to hyperdiploid', 'epithelial', '', '', 'monolayer', 'adenocarcinoma', 'adenocarcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Minimum essential medium (Eagle) in Earle', 'Dulbecco', '', 'Remove medium, rinse with fresh 0.25% trypsin solution, remove trypsin and let the culture sit at room temperature (or at 37C) until the cells detach (about 10 min). Add fresh medium, aspirate and dispense into new flasks. Subculture every 6 to 8 days.', '', '', '846', '1:2 to 1:5 is recommended.', '2 to 3 times weekly');
INSERT INTO `cellbank_production` VALUES ('777', '70827', 'HCC-827', 'Yes', '', 'lung', 'human', '', '', '', '', '', '', '', '', '', '', '', 'NSCLC, non small cell lung cancer', 'NSCLC, non small cell lung cancer', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', '', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Gazdar AF', '', '', '', '1753', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('778', '10023', 'Hep-2', 'Yes', '', 'larynx', 'human', '', 'poliovirus 1, adenovirus 3, vesicular stomatitis (Indiana)', '', 'negative', '', 'G6PD, A', '', 'epithelial', 'keratin', '', 'monolayer', 'carcinoma, epidermoid', 'carcinoma, epidermoid', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Eagle\'s Minimum Essential Medium in Earle\'s BSS, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Dulbecco\'s modified Eagle\'s medium, 90%; heat inactivated fetal bovine serum (FBS) 10%', '', '', 'Cytogenet Cell Genet, 48:19-24, 1988', 'the cells are positive for keratin by immunoperoxidase staining', '1764', '', '');
INSERT INTO `cellbank_production` VALUES ('779', '10121', 'HT-1080', 'Yes', '', '', 'human - male, 35 years old,  Caucasian', '', 'poliovirus 1; vesicular stomatitis (Indiana); RD114; feline leukemia virus (FeLV)', '', 'negative', 'yes, in immunosuppressed mice', 'G6PD, B', '', 'epithelial', '', '', 'monolayer', 'fibrosarcoma', 'fibrosarcoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Eagle', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', 'Cancer, 33:1027-1033, 1974', '', '2505', '', '');
INSERT INTO `cellbank_production` VALUES ('780', '88065', 'HepG2', 'Yes', '', 'liver', 'human', '', '', '', '', '', '', '', 'epithelial-like', '', '', 'monolayer', 'hepatoblastoma', 'hepatoblastoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Medium Eagle', 'Minimum essential medium, 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', 'Nature, 282:615, 1979', '', '14325', '', '');
INSERT INTO `cellbank_production` VALUES ('781', '70966', 'HCC-966', 'Yes', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', '', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Gazdar AF', '', '', '', '1114', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('782', '21589', 'IEC-18', 'Yes', '', 'ileum; epithelial', 'rat', '', '', '', '', '', '', '', 'epithelial', '', '', 'monolayer', 'normal', 'normal', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Dulbecco', 'DMEM 90%; fetal bovine serum (FBS), 10%', '', 'Remove medium, rinse monolayer with  fresh 0.25 % trypsin, 0.02 M EDTA solution, remove trypsin, add fresh medium, aspirate and dispense into new flasks.', 'Quaroni A et al. Epithelioid cell cultures from rat small intestine. Characterization by morphologic and immunologic criteria. J Cell Biol. 80: 248-265, 1979. Quaroni A and Isselbacher HJ. Cytotoxic effects and metabolism of benzopyrene and 7,12 - dimethylbenzanthracene in duodenal and ileal epithelial cell cultures. J. Natl. Cancer Inst. 67: 1353-1362, 1981.', '', '1668', '', '');
INSERT INTO `cellbank_production` VALUES ('783', '40152', 'Jurkat clone E6-1', 'Yes', '', 'blood', 'human', '', '', '', '', '', '', '', 'round', '', '', 'suspension', 'acute T cell leukemia', 'acute T cell leukemia', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', '', '', '4305', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('784', '22190', 'HK-2', 'Yes', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', '', 'RPMI1640, 90%; FBS, 10%', '', '', '', '', '921', '', '');
INSERT INTO `cellbank_production` VALUES ('785', '10137', 'HEL 299', 'Yes', '', 'lung', 'human - male, embryo, Black', '', 'vesicular stomatitis (Indiana); poliovirus 1', '', 'negative', '', 'G6PD, A', 'normal human male; diploid; stable', 'fibroblast', '', '', 'monolayer', 'normal', 'normal', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Eagle', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', 'Proc Soc Exp Biol Med, 128:722, 1968', '', '2220', '', '');
INSERT INTO `cellbank_production` VALUES ('786', '30040', 'HUTU 80', 'Yes', '', 'duodenum', 'human - male, 53 years old, Caucasian', '', '', '', '', 'Yes, in nude mice; forms well differentiated papillary adenocarcinoma, (grade I).', 'PGM3,1-2;PGM1,1-2;ES-D,1;Me-2,2;AK-1,1;GLO-1,2;G6PD,B', '(P12) hypodiploid to hyperdiploid', 'epithelial', '', '', 'monolayer', 'adenocarcinoma', 'adenocarcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Minimum essential medium (Eagle) in Earle', 'Dulbecco', '', 'Remove medium, rinse with fresh 0.25% trypsin solution, remove trypsin and let the culture sit at room temperature (or at 37C) until the cells detach (about 10 min). Add fresh medium, aspirate and dispense into new flasks. Subculture every 6 to 8 days.', '', '', '846', '1:2 to 1:5 is recommended.', '2 to 3 times weekly');
INSERT INTO `cellbank_production` VALUES ('787', '10186', 'IMR-90', 'Yes', '', 'lung', 'human - female, fetus, 16 weeks old, Caucasian', '', 'poliovirus 1,2,3; herpes simples 1,2; varicella zoster; vesicular stomatitis; cytomegalovirus; vaccinia', '', 'negative', '', 'G6PD,B', '', 'fibroblast', '', '', 'monolayer', 'normal', 'normal', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'MEM (Eagle) in Earle', 'Minimum Essential Medium, 90%, heat inactivated fetal bovine serum (FBS), 10%', '', '', 'Science, 196: 60-63, 1977', '', '1712', '', '');
INSERT INTO `cellbank_production` VALUES ('788', '70095', 'HCC-95', 'Yes', '', 'lung', 'human - male, 65 years old', '', '', '', '', '', '', '', 'epithelial', '', '', 'monolayer', 'squamous cell carcinoma', 'squamous cell carcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Gazdar AF', 'Remove medium, add fresh 0.25 % trypsin 0.02 % EDTA solution, stand culture flask at 37', 'Wistuba II et al., Comparison of features of human lung cancer cell lines and their corresponding tumors, Clin Cancer Res, 1999, 5:991-1000', '', '1383', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('789', '80015', 'KM12C', 'Yes', '', 'colon', 'human', '', '', '', '', '', '', '', '', '', '', 'monolayer', 'carcinoma, low metastatic', 'carcinoma, low metastatic', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Eagle', 'Minimum Essential Medium, 90%, heat inactivated fetal bovine serum (FBS), 10%', 'Isaiah J, Fidler', '', '', '', '1601', '', '');
INSERT INTO `cellbank_production` VALUES ('790', '22116', 'JC', 'Yes', '', 'mammary gland', 'Mus musculus', 'BALB/cRos', '', '', '', '', '', '', '', '', '', 'monolayer', 'adenocarcinoma', 'adenocarcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', '', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', '', '', '618', '', '');
INSERT INTO `cellbank_production` VALUES ('791', '70044', 'HCC-44', 'Yes', '', 'lung', '', '', '', '', '', '', '', '', '', '', '', '', 'NSCLC, non small cell lung cancer', 'NSCLC, non small cell lung cancer', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', '', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Gazdar AF', '', 'Cancer Res., 64, 4277-4285', '', '1117', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('792', '21592', 'IEC-6', 'Yes', '', 'ileum', 'rat', '', '', '', '', '', '', '', 'epithelial', '', '', 'monolayer', 'normal', 'normal', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Dulbecco\'s modified Eagle\'s medium with 4.5mM L-glutamine adjusted to contain 1.5g/L sodium bicarbonate, 4.5g/L glucose,1.0mM sodium pyruvate and supplemented with 0.1 unit/ml bovine insulin,95 %; heat inactivated fetal bovine serum (FBS), 5%', 'Dulbecco\'s modified Eagle\'s medium, 90%; heat inactivated fetal bovine serum (FBS) 10%', 'Quaroni A et al. Epithelioid cell cultures from rat small intestine. Characterization by morphologic and immunologic criteria. J. Cell Biol. 80:248-265, 1979.', 'Remove medium, rinse monolayer with  fresh 0.25 % trypsin, 0.02 M EDTA solution.After 1 minute add fresh medium, aspirate and dispense into new flasks.The depositor recommends scraping the cells for subcultivation after incubation with 0.5 Mm EDTA in PBS for 45 to 75 minutes.However, there is no evidence that the different subcultivation methods affect the properties of this line.', 'Quaroni A et al. Epithelioid cell cultures from rat small intestine. Characterization by morphologic and immunologic criteria. J. Cell Biol. 80:248-265, 1979.', 'Cell growth is inhibited by cortisol.The cells express antigens characteristic of intestine epithelia.The distribution stock is capable of 15 population doublings.', '1074', '', '');
INSERT INTO `cellbank_production` VALUES ('793', '10247', 'HCT 116', 'Yes', '', 'colon; colorectal', 'human - male', '', '', '', 'negative', 'yes, in nude mice', 'G6PD, B; PGM1, 1; PGM3, 1; ES-D, 1-2; AK-1, 1; GLO-1, 1', '', 'epithelial', 'carcinoembryonic antigen (CEA) 1 ng per 10exp6 cells per 10 days; keratin', '', 'monolayer', 'carcinoma', 'carcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'McCoy', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', 'Cancer Res, 41:1751-1756, 1981', 'the cells are positive for keratin by immunoperoxidase staining; growth and plating efficiency are enhanced by using a feeder layer of murine fibroblasts', '5728', '', '');
INSERT INTO `cellbank_production` VALUES ('794', '40184', 'J1j.10', 'Yes', '', 'B cell; B lymphocyte', 'rat', 'Lewis (B cell); BALB/c (myeloma)', '', '', '', 'yes, in immunosuppressed (B6 X CBA)F1 mice', 'IgM', '', 'lymphoblast', 'immunoglobulin; monoclonal antibody; against Thy-1.2 antigen; cytotoxic', '', 'suspension', 'hybridoma; mouse(myeloma)', 'hybridoma; mouse(myeloma)', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'MEM, 90%; horse serum, 10%', 'Dulbecco\'s modified Eagle\'s medium, 90%; heat inactivated fetal bovine serum (FBS) 10%', '', '', 'J immunol, 127; 2496-2501, 1981', 'animals were immunized with C3H/HeJ thymocytes; spleen cells were fused with Sp2/0-Ag14 myeloma cells; the antibody does not lyse Thy-1.1 cells; tested and found negative for ectromelia virus (mousepox)', '833', '', '');
INSERT INTO `cellbank_production` VALUES ('795', '9S0070', 'HCC-70', 'Yes', '', 'breast', 'human - female, 49 years old, black', '', '', '', '', '', '', '', 'epithelial', '', '', 'monolayer', 'ductal cancer', 'ductal cancer', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Adi F Gazdar', 'Remove medium, add fresh 0.25 % trypsin 0.02 % EDTA solution, stand culture flask at 37', 'Gazdar et al., Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer, Int J Cancer, 1998, 78:766-774', '', '901', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('796', '10121', 'HT-1080', 'Yes', '', '', 'human - male, 35 years old,  Caucasian', '', 'poliovirus 1; vesicular stomatitis (Indiana); RD114; feline leukemia virus (FeLV)', '', 'negative', 'yes, in immunosuppressed mice', 'G6PD, B', '', 'epithelial', '', '', 'monolayer', 'fibrosarcoma', 'fibrosarcoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Eagle', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', 'Cancer, 33:1027-1033, 1974', '', '2505', '', '');
INSERT INTO `cellbank_production` VALUES ('797', '22026', 'Hepa-1c1c7', 'Yes', '', 'liver', 'mouse - Mus musculus', 'C57L', '', '', '', '', '', '', 'epithelial', 'cytochrome P450IA1', '', 'monolayer', 'Hepatoma', 'Hepatoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Alpha minimum essential medium without nucleosides, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'minimum essential medium 90%; heat inactivated fetal bovine serum (FBS), 10%', '', 'Remove medium, add fresh 0.25% trypsin, 0.03% EDTA solution and let the culture sit at room temperature for 3 minutes. Remove the trypsin and allow the culture to sit an additional 5 minutes until they begin to detach. Add fresh medium, aspirate and dispense into new flasks.', 'Bernhard HP et al. Expression of liver phenotypes in cultured mouse hepatoma cells: synthesis and secretion of serum albumin. Dev.Biol. 35: 83-96, 1973. Hankinson O et al. Genetic and molecular analysis of the Ah receptor and of Cyp1a1 gene expression. Biochimie 73: 61-66, 1991. Hankinson O. Single-step selection of clones of a mouse hepatoma line deficient in aryl hydrocarbon hydroxylase. Proc.Natl.Acad.Sci.USA 76: 373-376, 1979', '', '3371', '1:4 to 1:10', 'twice weekly');
INSERT INTO `cellbank_production` VALUES ('798', '21473', 'HT-1197', 'Yes', '', 'bladder', 'human - male, 44 years old,  Caucasian', '', '', '', '', 'yes, in mice and hamsters', 'G6PD, B', '', '', 'fibrinolytic activity', '', 'monolayer', 'carcinoma', 'carcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'MEM (Eagle) in Earle', 'Minimum Essential Medium, 90%, heat inactivated fetal bovine serum (FBS), 10%', '', '', 'J Nat', 'the cells will grow in soft agar', '1144', '', '');
INSERT INTO `cellbank_production` VALUES ('799', '10127', 'IMR-32', 'Yes', '', '', 'human - male, 13 months old,  Caucasian', '', 'vesicular stomatitits (Indiana); herpes simplex; vaccinia; coxsackievirus B 3 ; poliovirus 3 (poorly)', 'echovirus 11', 'negative', '', 'G6PD, B', '', 'neuroblast; fibrobla', '', '', 'monolayer', 'neuroblastoma', 'neuroblastoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Eagle', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', '', 'Two cell types are present; predominant is a small neuroblast like cell; the other is a large hyaline fibroblast', '1321', '', '');
INSERT INTO `cellbank_production` VALUES ('800', '21472', 'HT-1376', 'Yes', '', 'bladder', 'human - female, 58 years old, Caucasian', '', '', '', 'negative', 'yes, in mice and hamsters', 'G6PD,B', '', 'epithelial', 'fibrinolytic activity; interferon', '', 'monolayer', 'carcinoma; cancer; Grade 3', 'carcinoma; cancer; Grade 3', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'MEM (Eagle) in Earle\'s BSS with non-essential amino acids, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Dulbecco\'s modified Eagle\'s medium, 90%; heat inactivated fetal bovine serum (FBS) 10%', '', '', 'J.Nat\'l.Cancer Inst.58:881-890, 1977; Arch. Virol. 62:209-219, 1979', 'the line does not contain detectable virus particles, herpesvirus antigens or retrovirus antigens; the cells will grow in soft agar', '1057', '', '');
INSERT INTO `cellbank_production` VALUES ('801', '10087', 'Jiyoye(P-2003)', 'Yes', '', 'B cell; B lymphocyte', 'human - male, Black, African', '', '', 'The cells are partially resistant to poliovirus and vesicular stomatit', 'negative', '', 'G6PD, B', '', 'lymphoblast', 'EBV', 'HLA A32, B17, Bw37', 'suspension', 'Burkitt\'s lymphoma', 'Burkitt\'s lymphoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640, 80%; heat inactivated fetal bovine serum (FBS), 20% or Iscove\'s modified Dulbecco\'s medium, 80%; FBS, 20%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', 'J Clin Path, 18:261, 1985', 'The cells carry and produce Epstein-Barr virus (EBV); EBNA positive; Biological Safety Class II', '1570', '', '');
INSERT INTO `cellbank_production` VALUES ('802', '30001', 'J82', 'Yes', '', 'bladder', 'human - male, 58 years old, Caucasian, Swedish', '', '', '', '', 'no', 'Me-2, 1-2; PGM3, 2; PGM1, 1; ES-D, 1; AK-1, 1; G6PD, B; GLO-1', '(P48) triploid with some tetraploid and hexaploid metaphases', 'epithelial', '', '', 'monolayer', 'carcinoma, transitional cell', 'carcinoma, transitional cell', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'MEM (Eagle) in Earle', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', 'Brit J Cancer, 38:64-76, 1978', 'electron microscopic examination did not reveal desmosomes but varying amounts of rough endoplasmic reticulum and prominent microfilaments were observed; contains the ras (H-ras) oncogene', '628', '', '');
INSERT INTO `cellbank_production` VALUES ('803', '21472', 'HT-1376', 'Yes', '', 'bladder', 'human - female, 58 years old, Caucasian', '', '', '', 'negative', 'yes, in mice and hamsters', 'G6PD,B', '', 'epithelial', 'fibrinolytic activity; interferon', '', 'monolayer', 'carcinoma; cancer; Grade 3', 'carcinoma; cancer; Grade 3', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'MEM (Eagle) in Earle\'s BSS with non-essential amino acids, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Dulbecco\'s modified Eagle\'s medium, 90%; heat inactivated fetal bovine serum (FBS) 10%', '', '', 'J.Nat\'l.Cancer Inst.58:881-890, 1977; Arch. Virol. 62:209-219, 1979', 'the line does not contain detectable virus particles, herpesvirus antigens or retrovirus antigens; the cells will grow in soft agar', '1057', '', '');
INSERT INTO `cellbank_production` VALUES ('804', '40067', 'J774A.1', 'Yes', '', 'monocyte; macrophage', 'mouse - female', 'BALB/c', '', '', '', '', '', '', 'macrophage', 'interleukin-1 (interleukin 1, IL-1, LAF); lysozyme', '', 'monolayer', 'macrophage', 'macrophage', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Dulbecco', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', 'Subcultures are prepared by scraping.', 'Nature, 257:393-394, 1975; J Immunol, 114:898-905, 1975; J Immunol, 119:950-954, 1977; Cancer Res, 37:546-550, 1977', 'active in antibody dependent phagocytosis; growth is inhibited by extran sulfate, PPD and LPS; tested and found negative for ectromelia virus (mousepox)', '3138', '', '');
INSERT INTO `cellbank_production` VALUES ('805', '30144', 'JAR', 'Yes', '', 'placenta', 'human - female, 24 years old, caucasian', '', '', '', '', '', '', '', 'epithelial', '', '', 'monolayer', 'choriocarcinoma', 'choriocarcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', 'Remove medium, add fresh 0.25 % trypsin 0.02 % EDTA solution, stand culture flask at 37', '', '', '649', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('806', '88065', 'HepG2', 'Yes', '', 'liver', 'human', '', '', '', '', '', '', '', 'epithelial-like', '', '', 'monolayer', 'hepatoblastoma', 'hepatoblastoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Medium Eagle', 'Minimum essential medium, 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', 'Nature, 282:615, 1979', '', '14325', '', '');
INSERT INTO `cellbank_production` VALUES ('807', '10244', 'HCT-8', 'Yes', '', 'colon; ileocecal; colorectal', 'human - male, 67 years old', '', '', '', '', 'yes, in nude mice', 'AK-1, 1; ES-D, 1-2; GLO-1, 2; G6PD, B; PGM1, 1; PGM3, 1; Me-2, 1', '', 'epithelial', 'carcinoembryonic antigen (CEA) 0.5ng/10 exp6 cells/10days; alkaline phosphatase; keratin', '', 'monolayer', 'adenocarcinoma', 'adenocarcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with sodium pyruvate (1 mM), 90%; horse serum, 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', 'J Nat\'l Cancer Inst, 52:1101-1110, 1974', 'the HCT-8 line is identical to the HRT-18 cell line; the cells are positive for keratin by immunoperoxidase staining', '1598', '', '');
INSERT INTO `cellbank_production` VALUES ('808', '10127', 'IMR-32', 'Yes', '', '', 'human - male, 13 months old,  Caucasian', '', 'vesicular stomatitits (Indiana); herpes simplex; vaccinia; coxsackievirus B 3 ; poliovirus 3 (poorly)', 'echovirus 11', 'negative', '', 'G6PD, B', '', 'neuroblast; fibrobla', '', '', 'monolayer', 'neuroblastoma', 'neuroblastoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Eagle', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', '', 'Two cell types are present; predominant is a small neuroblast like cell; the other is a large hyaline fibroblast', '1321', '', '');
INSERT INTO `cellbank_production` VALUES ('809', '21777', 'HIT-T15', 'No', '', 'pancreas; islet of Langerhans; beta cell', 'hamster - hamster', 'Syrian golden', '', '', '', '', '', '', 'epithelial', 'insulin', '', 'monolayer', '', '', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Ham\'s F 12K medium with 2mM  L-glutamine adjusted to contain 1.5g/L sodium bicarbonate, 87.5%; dialyzed horse serum, 10%; heat inactivated fetal bovine serum (FBS), 2.5 %', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', 'Remove medium, add fresh 0.25 % trypsin (enough to cover the monolayer) and let stand at room temperature until the cells detach. Add fresh medium, aspirate and dispense into new flasks at about 1.3 X exp5 cells per sq.cm.', 'Lord JM and Ashcroft SJ. Identification and chracterization of Ca2+ phospholipid-dependent protein kinase in rat islet and hamster beta-cells. Biochem. J. 219: 547-551, 1984.', 'This line was established from a primary culture of Syrian hamster islet cells which were transformed with SV40.The cells secrete up to 24ng of insulin in per 10 exp6 cells per 24 hours(passage 60).Insulin in secretion is stimulated by glucose and glucagon, and is suppressed by somatostatin and glucocorticoids.Insulin synthesis decreases with length of time in culture.', 'No', '', '');
INSERT INTO `cellbank_production` VALUES ('810', '70827', 'HCC-827', 'Yes', '', 'lung', 'human', '', '', '', '', '', '', '', '', '', '', '', 'NSCLC, non small cell lung cancer', 'NSCLC, non small cell lung cancer', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', '', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Gazdar AF', '', '', '', '1753', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('811', '10002.1', 'HeLa 229', 'Yes', '', 'cervix, uterine', 'human - female, 31 years old; Black', '', 'vesicular stomatitis (Indiana); adenovirus 3', 'poliovirus 1,2,3', 'negative', '', 'G6PD, A', '', 'epithelial', 'keratin', '', 'monolayer', 'adenocarcinoma', 'adenocarcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Eagle', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', 'Scherer in 1952', 'This cells can be adapted to growth in suspension.; relatively resistant to polioviruses.; positive for keratin by immunoperoxidases staining', '3052', '', '');
INSERT INTO `cellbank_production` VALUES ('812', '27649', 'Hs903.T', 'Yes', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', '', '', '', '', '', '', '1102', '', '');
INSERT INTO `cellbank_production` VALUES ('813', '10002', 'HeLa', 'Yes', '', 'cervix, uterine', 'human - female, 31 years old; Black', '', 'poliovirus 1,2,3; adenovirus 3, encephalomyocarditis; coxsachievirus B serotypes', '', 'negative', '', 'G6PD, A', '', 'epithelial', 'keratin', '', 'monolayer', 'adenocarcinoma', 'adenocarcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Eagle', 'Minimum Essential Medium, 90%, heat inactivated fetal bovine serum (FBS), 10%', '', '', 'Cancer Res. 12:264, 1952; Cytonent Cell Genet, 48:19-24, 1988', 'the cells are positive for keratin by immunoperoxidase staining', '10395', '', '');
INSERT INTO `cellbank_production` VALUES ('814', '30103', 'KATO III', 'Yes', '', 'stomach', 'human - male, 55 years old, Mongoloid', '', '', '', '', 'tumors not produced', 'PGM1, 1; PGM3, 1; ES D, 1; AK1, 1; GLO-1,2; G6PD, B', '', 'spherical', '', '', 'mixed, adherent and ', 'carcinoma, pleural effusion with metastases to supraclavicular and axillary lymph nodes', 'carcinoma, pleural effusion with metastases to supraclavicular and axillary lymph nodes', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Iscove', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', '', '', '2695', '', '');
INSERT INTO `cellbank_production` VALUES ('815', '27648', 'HS903.SK', 'Yes', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', '', '', '', '', '', '', '1065', '', '');
INSERT INTO `cellbank_production` VALUES ('816', '27701', 'HF282.Sp', 'Yes', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', '', '', '', '', '', '', '117', '', '');
INSERT INTO `cellbank_production` VALUES ('817', '80014', 'KM12L4', 'Yes', '', 'colon', 'human', '', '', '', '', '', '', '', '', '', '', 'monolayer', 'carcinoma, highly metastatic', 'carcinoma, highly metastatic', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Eagle', 'Dulbecco', 'Isaiah J, Fidler', '', '', '', '1107', '', '');
INSERT INTO `cellbank_production` VALUES ('818', '10225', 'HCT-15', 'Yes', '', 'colon', 'human', '', '', '', 'negative', 'yes, in nude mice', 'G6PD,B;PGM1,1-2;PGM3,1;6PGD,A;ES-D,2;PEP-D,1', '', 'epithelial', 'carcinoembryonic antigen (CEA) 5.4ng/10 exp6 cells/10days; keratin', 'blood type O', 'monolayer', 'adenocarcinoma', 'adenocarcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640, 80%; heat inactivated fetal bovine serum (FBS), 20%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', 'Cancer Res. 39:1020-1025, 1979', 'CSAp negative (CSAp-); the cells are positive for keratin by immunoperoxidase staining', '2081', '', '');
INSERT INTO `cellbank_production` VALUES ('819', '30038', 'HT-29', 'Yes', '', 'colon', 'human - female, 44 years old, Caucasian', '', 'human immunodeficiency virus (HIV,LAV)', '', '', 'Yes, in nude mice forms well differentiated adenocarcinoma consistent with colonic primary(grade I); tumors also form in steroid treated hamsters.', 'Me-2,1;PGM3,1-2;PGM1,1-2;ES-D,1;AK-1,1;GLO-1,1-2;G6PD,B', '', 'epithelial', 'Secretory component of IgA; carcinoembryonic antigen(CEA); transforming growth factor beta binding protein; mucin', '', 'monolayer', 'adenocarcinoma', 'adenocarcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'McCoy\'s 5a medium with 1.5mM L-glutamine, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', 'Remove medium, rinse with fresh 0.25% trypsin solution, remove trypsin and let the culture sit at room temperature (or 37C) until the cells detach (about 10min). Add fresh medium, aspirate and dispense into new flasks. Subculture every 6 to 8 days.', 'Fogh J., ed., Human tumor cells in vitro. New York: Plenum Press; 1975: pp.115-159Chen TR et al. WiDr is a derivative of another colon adenocarcinoma cell line, HT-29. Cancer Genet.Cytogenet. 27: 125-134, 1987', '', '7396', '1:3 to 1:8 is recommended', '2 to 3 times weekly');
INSERT INTO `cellbank_production` VALUES ('820', '40152', 'Jurkat clone E6-1', 'Yes', '', 'blood', 'human', '', '', '', '', '', '', '', 'round', '', '', 'suspension', 'acute T cell leukemia', 'acute T cell leukemia', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', '', '', '4305', '', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('821', '10159', 'IM-9', 'Yes', '', 'B cell; B lymphoblast', 'human - female, Caucasian', '', '', '', 'negative', '', 'PGM1,1-2;PGM3,0;ES-D,1;Me-2,2;GLO-1,1-2;G6PD,B;IgG', '', 'lymphoblast', 'Immunoglobulin', '', 'suspension', 'multiple myeloma; plasmacytoma', 'multiple myeloma; plasmacytoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640, 90% (80%); heat inactivated fetal bovine serum (FBS), 10% (or 20%)', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', 'Ann NY Acad Sci, 190:221-234, 1972', 'The cells are EBNA positive', '1495', '', '');
INSERT INTO `cellbank_production` VALUES ('822', '10023', 'Hep-2', 'Yes', '', 'larynx', 'human', '', 'poliovirus 1, adenovirus 3, vesicular stomatitis (Indiana)', '', 'negative', '', 'G6PD, A', '', 'epithelial', 'keratin', '', 'monolayer', 'carcinoma, epidermoid', 'carcinoma, epidermoid', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Eagle\'s Minimum Essential Medium in Earle\'s BSS, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Dulbecco\'s modified Eagle\'s medium, 90%; heat inactivated fetal bovine serum (FBS) 10%', '', '', 'Cytogenet Cell Genet, 48:19-24, 1988', 'the cells are positive for keratin by immunoperoxidase staining', '1764', '', '');
INSERT INTO `cellbank_production` VALUES ('823', '30038', 'HT-29', 'Yes', '', 'colon', 'human - female, 44 years old, Caucasian', '', 'human immunodeficiency virus (HIV,LAV)', '', '', 'Yes, in nude mice forms well differentiated adenocarcinoma consistent with colonic primary(grade I); tumors also form in steroid treated hamsters.', 'Me-2,1;PGM3,1-2;PGM1,1-2;ES-D,1;AK-1,1;GLO-1,1-2;G6PD,B', '', 'epithelial', 'Secretory component of IgA; carcinoembryonic antigen(CEA); transforming growth factor beta binding protein; mucin', '', 'monolayer', 'adenocarcinoma', 'adenocarcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'McCoy\'s 5a medium with 1.5mM L-glutamine, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', 'Remove medium, rinse with fresh 0.25% trypsin solution, remove trypsin and let the culture sit at room temperature (or 37C) until the cells detach (about 10min). Add fresh medium, aspirate and dispense into new flasks. Subculture every 6 to 8 days.', 'Fogh J., ed., Human tumor cells in vitro. New York: Plenum Press; 1975: pp.115-159Chen TR et al. WiDr is a derivative of another colon adenocarcinoma cell line, HT-29. Cancer Genet.Cytogenet. 27: 125-134, 1987', '', '7396', '1:3 to 1:8 is recommended', '2 to 3 times weekly');
INSERT INTO `cellbank_production` VALUES ('824', '10159', 'IM-9', 'Yes', '', 'B cell; B lymphoblast', 'human - female, Caucasian', '', '', '', 'negative', '', 'PGM1,1-2;PGM3,0;ES-D,1;Me-2,2;GLO-1,1-2;G6PD,B;IgG', '', 'lymphoblast', 'Immunoglobulin', '', 'suspension', 'multiple myeloma; plasmacytoma', 'multiple myeloma; plasmacytoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640, 90% (80%); heat inactivated fetal bovine serum (FBS), 10% (or 20%)', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', 'Ann NY Acad Sci, 190:221-234, 1972', 'The cells are EBNA positive', '1495', '', '');
INSERT INTO `cellbank_production` VALUES ('825', '80013', 'K-1735', 'Yes', '', '', 'murine', '', '', '', '', '', '', '', '', '', '', 'monolayer', 'melanoma', 'melanoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Eagle', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'Isaiah J, Fidler', '', '', '', '1231', '', '');
INSERT INTO `cellbank_production` VALUES ('826', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '');
INSERT INTO `cellbank_production` VALUES ('827', '21473', 'HT-1197', 'Yes', '', 'bladder', 'human - male, 44 years old,  Caucasian', '', '', '', '', 'yes, in mice and hamsters', 'G6PD, B', '', '', 'fibrinolytic activity', '', 'monolayer', 'carcinoma', 'carcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'MEM (Eagle) in Earle', 'Minimum Essential Medium, 90%, heat inactivated fetal bovine serum (FBS), 10%', '', '', 'J Nat', 'the cells will grow in soft agar', '1144', '', '');
INSERT INTO `cellbank_production` VALUES ('828', '30036', 'JEG3', 'Yes', '', 'placenta', 'human', '', '', '', '', '', '', '', 'epithelial', '', '', 'monolayer', 'choriocarcinoma', 'choriocarcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Eagle\'s Minimum Essential Medium, 90%; heat inactivated fetal bovine serum (FBS), 10% or Dulbecco\'s modified Eagle\'s Medium, 90%, heat inactivated fetal bovine serum (FBS), 10%, antibiotic free', 'Eagle\'s Minimum Essential Medium, 90%; heat inactivated fetal bovine serum (FBS), 10% or Dulbecco\'s modified Eagle\'s Medium, 90%, heat inactivated fet', '', 'Remove culture medium and rinse the cell sheet with fresh 0.25 % trypsin. Remove trypsin, and allow the culture to sit at 37\'C for 10 minutes. Add fresh medium, aspirate and dispense into new flasks.', '', '', '666', '1:2', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('829', '21723', 'L5178-S(LY-S)', 'Yes', '', 'thymus', 'mouse', 'DBA/2', '', '', '', 'yes, in DBA/2 mice (but only weakly)', '', '', 'lymphoblast', '', '', 'suspension', 'lymphoma; chemically induced', 'lymphoma; chemically induced', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Fischer\'s medium with 0.1g/L sodium pyruvate and 1.125g/L sodium bicarbonate, 90%; horse serum, 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', 'Cancer Res, 43:4736-4742, 1983; Brit J Cancer, 49:107-111; Int J Radiat, 48:609-619, 1985', 'this line was derived from the X-ray resistant L5178-R line (KCLB 21722); the cells are sensitive to X-rays, ultraviolet radiation, heat and some potential anti neoplastic drugs (e.g., cis-PAD); the parental cell line was derived from the L5178 thymic lymphoma induced by methylcholanthrene in a DBA/2 mouse; tested and found negative for ectromelia virus (mousepox)', '715', '', '');
INSERT INTO `cellbank_production` VALUES ('830', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '');
INSERT INTO `cellbank_production` VALUES ('831', '60104', 'Huh7', 'Yes', '', 'liver', 'human', '', '', '', '', '', '', '', '', '', '', 'epithelial-like', '', '', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', '', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', 'cells are treated with 0.2% trypsin and 0.02% EDTA', '', '', '5307', '', '');
INSERT INTO `cellbank_production` VALUES ('832', '30103', 'KATO III', 'Yes', '', 'stomach', 'human - male, 55 years old, Mongoloid', '', '', '', '', 'tumors not produced', 'PGM1, 1; PGM3, 1; ES D, 1; AK1, 1; GLO-1,2; G6PD, B', '', 'spherical', '', '', 'mixed, adherent and ', 'carcinoma, pleural effusion with metastases to supraclavicular and axillary lymph nodes', 'carcinoma, pleural effusion with metastases to supraclavicular and axillary lymph nodes', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Iscove', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', '', '', '2695', '', '');
INSERT INTO `cellbank_production` VALUES ('833', '10186', 'IMR-90', 'Yes', '', 'lung', 'human - female, fetus, 16 weeks old, Caucasian', '', 'poliovirus 1,2,3; herpes simples 1,2; varicella zoster; vesicular stomatitis; cytomegalovirus; vaccinia', '', 'negative', '', 'G6PD,B', '', 'fibroblast', '', '', 'monolayer', 'normal', 'normal', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'MEM (Eagle) in Earle', 'Minimum Essential Medium, 90%, heat inactivated fetal bovine serum (FBS), 10%', '', '', 'Science, 196: 60-63, 1977', '', '1712', '', '');
INSERT INTO `cellbank_production` VALUES ('834', '10219', 'L1210', 'Yes', '', 'lymphocyte', 'mouse - female, 8 months old', 'DBA subline 212; female #234', '', '', 'positive', 'yes, in nude mouse', '', '', 'lymphoblast', '', '', 'suspension', 'leukemia', 'leukemia', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Dulbecco\'s modified Eagle\'s Medium, with 4.5g/L glucose, 90%; horse serum, 10% - OR - Fischer\'s medium, 90%; horse serum, 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', 'J Nat\'l Cancer Inst, 10:179-192, 1949', 'tested and found negative for ectromelia virus (mousepox)', '1328', '', '');
INSERT INTO `cellbank_production` VALUES ('835', '27649', 'Hs903.T', 'Yes', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', '', '', '', '', '', '', '1102', '', '');
INSERT INTO `cellbank_production` VALUES ('836', '80015', 'KM12C', 'Yes', '', 'colon', 'human', '', '', '', '', '', '', '', '', '', '', 'monolayer', 'carcinoma, low metastatic', 'carcinoma, low metastatic', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Eagle', 'Minimum Essential Medium, 90%, heat inactivated fetal bovine serum (FBS), 10%', 'Isaiah J, Fidler', '', '', '', '1601', '', '');
INSERT INTO `cellbank_production` VALUES ('837', '21722', 'L5178-R(LY-R)', 'Yes', '', 'thymus', 'mouse', 'DBA/2', '', '', '', 'yes, in DBA/2 mice', '', '', 'lymphoblast', '', '', 'suspension', 'lymphoma; chemically induced', 'lymphoma; chemically induced', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Fischer\'s medium with 0.1g/L sodium pyruvate and 1.125g/L sodium bicarbonate, 90%; horse serum, 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', 'Cancer Res, 43:4736-4742, 1983; Brit J Cancer, 49:107-111, 1984; Int J Radiat, 48:609-619, 1985', 'this cell line was derived from the L5178 thymic lymphoma induced by methylcholanthrene in a DBA/2 mouse; the cells are resistant to X-rays, but sensitive to ultraviolet radiation, heat and some potential anti neoplastic drugs (e.g., cis-PAD); after 6 months to 3 years in culture, the line converts to an X-ray sensitive state; the X-ray sensitive L5178-S line (KCLB 21723) was derived from this line; tested and found negative for ectromelia virus (mousepox)', '797', '', '');
INSERT INTO `cellbank_production` VALUES ('838', '10017', 'KB', 'Yes', '', 'HeLa contaminant', 'human', '', 'poliovirus 1; adenovirus 3', '', '', '', '', '', 'epithelial', 'keratin', '', 'monolayer', 'carcinoma', 'carcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Eagle', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', 'Proc Soc Exp Biol Med, 89:362, 1955', 'The cells are positive for keratin by immunoperoxidase staining. This cell line is Hela contaminant. DNA fingerprinting analysis of this cell line shows HeLa markers.', '2929', '', '');
INSERT INTO `cellbank_production` VALUES ('839', '10005', 'L-132', 'Yes', '', 'lung', 'human - embryo', '', 'poliovirus 1,2,3; adenovirus 3; vesicular stomatitis (Indiana)', '', 'negative', '', 'G6PD, A', '', 'epithelial', 'keratin', '', 'monolayer', 'normal', 'normal', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Medium 199, 80%; heat inactivated bovine calf serum (BCS), 20%', 'Dulbecco', '', '', 'Fed Proc, 19:386, 1960', 'the cells are positive for keratin by immunoperoxidase stainingThis line was originally thought to be derived from embryonic lung tissue, but was subsequently found, based on isoenzyme analysis, HeLa marker chromosomes, and DNA fingerprinting, to have been established via HeLa cell contamination.', '2277', '', '');
INSERT INTO `cellbank_production` VALUES ('840', '30036', 'JEG3', 'Yes', '', 'placenta', 'human', '', '', '', '', '', '', '', 'epithelial', '', '', 'monolayer', 'choriocarcinoma', 'choriocarcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Eagle\'s Minimum Essential Medium, 90%; heat inactivated fetal bovine serum (FBS), 10% or Dulbecco\'s modified Eagle\'s Medium, 90%, heat inactivated fetal bovine serum (FBS), 10%, antibiotic free', 'Eagle\'s Minimum Essential Medium, 90%; heat inactivated fetal bovine serum (FBS), 10% or Dulbecco\'s modified Eagle\'s Medium, 90%, heat inactivated fet', '', 'Remove culture medium and rinse the cell sheet with fresh 0.25 % trypsin. Remove trypsin, and allow the culture to sit at 37\'C for 10 minutes. Add fresh medium, aspirate and dispense into new flasks.', '', '', '666', '1:2', 'Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days');
INSERT INTO `cellbank_production` VALUES ('841', '10243', 'K-562', 'Yes', '', 'blood', 'human - female', '', '', '', '', '', '', '', 'lymphoblast-like', '', '', 'suspension', 'leukemia, chronic myelogenous', 'leukemia, chronic myelogenous', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', 'Blood, 45:321-333, 1975', '', '3445', '', '');
INSERT INTO `cellbank_production` VALUES ('842', '80016', 'KM12SM', 'Yes', '', 'colon', 'human', '', '', '', '', '', '', '', '', '', '', 'monolayer', 'carcinoma, highly metastatic', 'carcinoma, highly metastatic', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', 'Eagle', 'Dulbecco���s Modified Eagle���s Medium, 90%, heat inactivated fetal bovine serum (FBS), 10%', 'Isaiah J, Fidler', '', '', '', '1374', '', '');
INSERT INTO `cellbank_production` VALUES ('843', '22116', 'JC', 'Yes', '', 'mammary gland', 'Mus musculus', 'BALB/cRos', '', '', '', '', '', '', '', '', '', 'monolayer', 'adenocarcinoma', 'adenocarcinoma', 'RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%', '', 'RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%', '', '', '', '', '618', '', '');
